Does the liver accelerate ageing: Talking muscles and liver? (Unknown)
- New search for: Trenell, Michael I.
- New search for: Marchesini, Giulio
- New search for: Trenell, Michael I.
- New search for: Marchesini, Giulio
In:
Journal of hepatology
;
66
, 1
;
8-10
;
2017
-
ISSN:
- Article (Journal) / Print
-
Title:Does the liver accelerate ageing: Talking muscles and liver?
-
Contributors:Trenell, Michael I. ( author ) / Marchesini, Giulio ( author )
-
Published in:Journal of hepatology ; 66, 1 ; 8-10
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2017-01-01
-
Size:3 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:Unknown
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 66, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
From the Editor’s desk...Moreau, Richard / Bataller, Ramon / Berg, Thomas / Zucman-Rossi, Jessica / Jalan, Rajiv et al. | 2017
- 5
-
Bad memories from the gut may cause nightmares for the bile ductsFickert, Peter et al. | 2017
- 8
-
Does the liver accelerate ageing: Talking muscles and liver?Trenell, Michael I. / Marchesini, Giulio et al. | 2017
- 11
-
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised studyFung, Scott / Kwan, Peter / Fabri, Milotka / Horban, Andrzej / Pelemis, Mijomir / Hann, Hie-Won / Gurel, Selim / Caruntu, Florin A. / Flaherty, John F. / Massetto, Benedetta et al. | 2017
- 19
-
Mortality in hepatitis C patients who achieve a sustained viral response compared to the general populationInnes, Hamish / McDonald, Scott / Hayes, Peter / Dillon, John F. / Allen, Sam / Goldberg, David / Mills, Peter R. / Barclay, Stephen T. / Wilks, David / Valerio, Heather et al. | 2017
- 28
-
High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver diseaseHedegaard, Ditte L. / Tully, Damien C. / Rowe, Ian A. / Reynolds, Gary M. / Bean, David J. / Hu, Ke / Davis, Christopher / Wilhelm, Annika / Ogilvie, Colin B. / Power, Karen A. et al. | 2017
- 39
-
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patientsPol, Stanislas / Bourliere, Marc / Lucier, Sandy / Hezode, Christophe / Dorival, Céline / Larrey, Dominique / Bronowicki, Jean-Pierre / Ledinghen, Victor D.E. / Zoulim, Fabien / Tran, Albert et al. | 2017
- 48
-
Time trends of chronic HBV infection over prior decades – A global analysisOtt, Jördis J. / Horn, Johannes / Krause, Gérard / Mikolajczyk, Rafael T. et al. | 2017
- 55
-
Continuous de novo generation of spatially segregated hepatitis C virus replication organelles revealed by pulse-chase imagingWang, Hongliang / Tai, Andrew W. et al. | 2017
- 67
-
Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCCHocquelet, Arnaud / Aubé, Christophe / Rode, Agnès / Cartier, Victoire / Sutter, Olivier / Manichon, Anne Frederique / Boursier, Jérome / N’kontchou, Gisèle / Merle, Philippe / Blanc, Jean-Frédéric et al. | 2017
- 75
-
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine modelLi, Guangfu / Liu, Dai / Cooper, Timothy K. / Kimchi, Eric T. / Qi, Xiaoqiang / Avella, Diego M. / Li, Ningfei / Yang, Qing X. / Kester, Mark / Rountree, C. Bart et al. | 2017
- 86
-
Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injuryGuixé-Muntet, Sergi / de Mesquita, Fernanda Cristina / Vila, Sergi / Hernández-Gea, Virginia / Peralta, Carmen / García-Pagán, Juan Carlos / Bosch, Jaime / Gracia-Sancho, Jordi et al. | 2017
- 95
-
Metabolic preconditioning protects BSEP/ABCB11−/− mice against cholestatic liver injuryFuchs, Claudia D. / Paumgartner, Gustav / Wahlström, Annika / Schwabl, Philipp / Reiberger, Thomas / Leditznig, Nadja / Stojakovic, Tatjana / Rohr-Udilova, Nataliya / Chiba, Peter / Marschall, Hanns-Ulrich et al. | 2017
- 102
-
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophagesRaggi, Chiara / Correnti, Margherita / Sica, Antonio / Andersen, Jesper B. / Cardinale, Vincenzo / Alvaro, Domenico / Chiorino, Giovanna / Forti, Elisa / Glaser, Shannon / Alpini, Gianfranco et al. | 2017
- 116
-
Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel diseaseHenriksen, Eva Kristine Klemsdal / Jørgensen, Kristin Kaasen / Kaveh, Fatemeh / Holm, Kristian / Hamm, David / Olweus, Johanna / Melum, Espen / Chung, Brian K. / Eide, Tor J. / Lundin, Knut E.A. et al. | 2017
- 123
-
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosisKoo, Bo Kyung / Kim, Donghee / Joo, Sae Kyung / Kim, Jung Ho / Chang, Mee Soo / Kim, Byeong Gwan / Lee, Kook Lae / Kim, Won et al. | 2017
- 132
-
Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver diseaseGariani, Karim / Ryu, Dongryeol / Menzies, Keir J. / Yi, Hyon-Seung / Stein, Sokrates / Zhang, Hongbo / Perino, Alessia / Lemos, Vera / Katsyuba, Elena / Jha, Pooja et al. | 2017
- 142
-
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic reviewHashida, Ryuki / Kawaguchi, Takumi / Bekki, Masafumi / Omoto, Masayuki / Matsuse, Hiroo / Nago, Takeshi / Takano, Yoshio / Ueno, Takato / Koga, Hironori / George, Jacob et al. | 2017
- 153
-
EASL Recommendations on Treatment of Hepatitis C 2016| 2017
- 195
-
The genetics of alcohol dependence and alcohol-related liver diseaseStickel, Felix / Moreno, Christophe / Hampe, Jochen / Morgan, Marsha Y. et al. | 2017
- 212
-
Liver sinusoidal endothelial cells: Physiology and role in liver diseasesPoisson, Johanne / Lemoinne, Sara / Boulanger, Chantal / Durand, François / Moreau, Richard / Valla, Dominique / Rautou, Pierre-Emmanuel et al. | 2017
- 228
-
Determinants of hepatic effector CD8+ T cell dynamicsBenechet, Alexandre Pierre / Iannacone, Matteo et al. | 2017
- 234
-
Molecular targets for HCC and future treatmentsAllaire, Manon / Nault, Jean-Charles et al. | 2017
- 236
-
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?Zavaglia, Claudio / Okolicsanyi, Stefano / Cesarini, Lucia / Mazzarelli, Chiara / Pontecorvi, Valerio / Ciaccio, Antonio / Strazzabosco, Mario / Belli, Luca Saverio et al. | 2017
- 237
-
Hepatitis C testing in U.S. veterans born 1945–1965: An updateRoss, David B. / Belperio, Pamela S. / Chartier, Maggie / Backus, Lisa I. et al. | 2017
- 239
-
Reply to: “Hepatitis C testing in U.S. veterans born 1945–1965: An update”Justice, Amy C. / Esserman, Denise / Sarkar, Souvik / Levin, Forrest L. / Skanderson, Melissa / Lim, Joseph K. et al. | 2017
- 240
-
The anti-inflammatory role of propranolol in cirrhosis: Preventing the inflammatory exhaustion?Brito-Azevedo, Anderson / Perez, Renata de Mello / Coelho, Henrique Sérgio Moraes / Fernandes, Eduardo de Souza Martins / Castiglione, Raquel Carvalho / Villela-Nogueira, Cristiane Alves / Bouskela, Eliete et al. | 2017
- 242
-
Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infectionvan der Valk, Marc / Zaaijer, Hans L. / Kater, Arnon P. / Schinkel, Janke et al. | 2017
- 243
-
The association between sarcopenia and non-alcoholic fatty liver diseaseHu, Yi-Bing / Chen, Ze / Fu, Rong-Quan et al. | 2017
- 244
-
Reply to: “The association between sarcopenia and non-alcoholic fatty liver disease”Koo, Bo Kyung / Kim, Donghee / Joo, Sae Kyung / Kim, Jung Ho / Chang, Mee Soo / Kim, Byeong Gwan / Lee, Kook Lae / Kim, Won et al. | 2017
- 246
-
Are we still searching for the fifth element of MELD?Thevenot, Thierry / Weil, Delphine / Cervoni, Jean-Paul / Villamil, Federico G. / Di Martino, Vincent et al. | 2017
- 247
-
Reply to: “Are we still searching for the fifth element of MELD?”Solà, Elsa / Kerbert, Annarein / Coenraad, Minneke / Ginès, Pere et al. | 2017
- 248
-
Procoagulant imbalance in patients with non-alcoholic fatty liver diseaseTripodi, Armando / Fracanzani, Anna L. / Chantarangkul, Veena / Primignani, Massimo / Fargion, Silvia et al. | 2017
- 250
-
Reply to: “Procoagulant imbalance in patients with non-alcoholic fatty liver disease”Potze, Wilma / Sanyal, Arun J. / Lisman, Ton et al. | 2017
- 252
-
Erratum to “Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient”Löffler, Markus W. / Chandran, P. Anoop / Laske, Karoline / Schroeder, Christopher / Bonzheim, Irina / Walzer, Mathias / Hilke, Franz J. / Trautwein, Nico / Kowalewski, Daniel J. / Schuster, Heiko et al. | 2017
- 255
-
Acknowledgement to our reviewers| 2017
- S1
-
Multicenter randomized trial comparing short-term stenting versus balloon dilatation for dominant strictures in primary sclerosing cholangitisPonsioen, C. / Arnelo, U. / Bergquist, A. / Rauws, E. / Paulsen, V. / Cantu, P. / Parzanese, I. / de Vries, E. / Said, K. / Chazouilleres, O. et al. | 2017
- S2
-
Changes in fibrosis, but not the NAFLD Activity Score (NAS), are associated with disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosisSanyal, A. / Harrison, S. / Ratziu, V. / Abdelmalek, M. / Diehl, A. / Caldwell, S. / Shiffman, M. / Aguilar, R. / Jia, C. / McColgan, B. et al. | 2017
- S3
-
EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosisForns, X. / Lee, S. / Valdes, J. / Lens, S. / Ghalib, R. / Aguilar, H. / Felizarta, F. / Hassanein, T. / Hinrichsen, H. / Rincon, D. et al. | 2017
- S4
-
Common variation near glial-derived neurotrophic factor is associated with progression of hepatic collagen content in a genome-wide association study of liver fibrosis phenotypes in patients with primary sclerosing cholangitisShea, P. / Hirschfield, G. / Shiffman, M. / McColgan, B. / Goodman, Z. / Myers, R. / Subramanian, M. / Eksteen, B. / Janssen, H. / Bowlus, C. et al. | 2017
- S5
-
Improvement of gene therapy for Wilson’s diseaseMurillo-Sauca, O. / Moreno-Luqui, D. / Gazquez, C. / Navarro-Blasco, I. / Hernández-Alcoceba, R. / González-Aseguinolaza, G. et al. | 2017
- S6
-
Ileo-anal pouch anastomosis negatively impacts graft survival following liver transplantation for primary sclerosing cholangitisTrivedi, P.J. / Reece, J. / Laing, R.W. / Slaney, E. / Cooney, R. / Iqbal, T. / Gunson, B. / Thompson, F. / Mueisan, P. / Hirschfield, G.M. et al. | 2017
- S7
-
Comparison of continuous plasma diafiltration therapy and conventional therapy in critical patients with acute liver failureNishikawa, M. / Taniguchi, T. / Okajima, M. / Kaneko, S. et al. | 2017
- S8
-
Neutrophil dysfunction is potentially predictive of mortality and multi-organ failure in acute decompensation and acute-on-chronic liver failure patientsLu, H. / Macnaughtan, J. / Sawhney, R. / Jones, H. / Holland-Fischer, P. / Ghasemi, M. / Wright, G. / Davies, N. / Mookerjee, R.P. / Jalan, R. et al. | 2017
- S9
-
The level of hepatocyte death biomarkers correlates with severity and predicts early mortality in patients with acute decompensation with or without acute-on-chronic liver failureCao, Z. / Chen, L. / Wang, Y. / Yan, L. / Liu, Y. / Liu, K. / Li, F. / Xiang, X. / Tang, W. / Xie, J. et al. | 2017
- S10
-
New diagnostic algorithm of acute kidney injury in cirrhosis that includes categorization of stage 1 and assessment of urine NGAL. Relevance for the differential diagnosis and clinical outcomesHuelin, P. / Elia, C. / Solà, E. / Solé, C. / Moreira, R. / Carol, M. / Fabrelles, N. / Risso, À. / Albertos, S. / Glavin, E. et al. | 2017
- S12
-
Molecular predictors of recurrence prevention with sorafenib as adjuvant therapy in hepatocellular carcinoma: Biomarker study of the STORM phase III trialPinyol, R. / Montal, R. / Takayama, T. / Chau, G.-Y. / Mazzaferro, V. / Roayaie, S. / Lee, H.C. / Poon, R.T.-P. / Kokudo, N. / Zhang, Z. et al. | 2017
- S13
-
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: a multicentre cohort studyVitale, A. / Farinati, F. / Huo, T.-L. / Trevisani, F. / Giannini, E.G. / Piscaglia, F. / Cillo, U. et al. | 2017
- S14
-
Development and validation of a survival calculator for hepatocellular carcinoma patients undergoing liver transplantation: the Metroticket 2.0 modelSposito, Carlo / Cucchetti, Alessandro / Zhou, Jian / Pinna, Antonio D. / De Carlis, Luciano / Bongini, Marco / Cescon, Matteo / Fan, Jia / Di Sandro, Stefano / Yi-feng, He et al. | 2017
- S15
-
Risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance – a territory-wide analysis of 5181 patientsChan, H.L.Y. / Yip, T.C.F. / Wong, V.W.S. / Tse, Y.K. / Wong, G.L.H. et al. | 2017
- S16
-
YH25724, a novel long-acting GLP-1/FGF21 dual agonist lowers both non-alcoholic fatty liver disease activity score and fibrosis stage in a diet-induced obese mouse model of biopsy-confirmed non-alcoholic steatohepatitisHong, H.N. / Kim, J.H. / Choi, H.H. / Kim, D. / Kim, T.W. / Tølbøl, K.S. / Feigh, M. / Illemann, M. / Rigbolt, K. / Vrang, N. et al. | 2017
- S18
-
FXR agonists with sustained systemic rather than transient intestinal exposure are more efficacious in a diet-induced obese non-alcoholic steatohepatitis mouse modelWagner, B. / Brigham, D. / Lee, K.-J. / Ortiz, A. / Lu, N. / Qian, J. / Douglas, K. / Nagasawa, J. / Govek, S. / Feigh, M. et al. | 2017
- S19
-
Combination of an ASK1 inhibitor and FXR agonist increases efficacy in a mouse model of non-alcoholic steatohepatitisLiles, J.T. / Zagorska, A. / Hollenback, D. / Budas, G.R. / Liu, H. / Liu, K. / Brockett, R. / Shauf, A. / Tumas, D. / Breckenridge, D.G. et al. | 2017
- S20
-
HCV eradication reduces the occurrence of major adverse cardiovascular events in hepatitis C cirrhotic patients: data from the prospective ANRS CO12 CirVir cohortCacoub, P. / Nahon, P. / Layese, R. / Bourcier, V. / Cagnot, C. / Marcellin, P. / Guyader, D. / Pol, S. / Larrey, D. / Roudot-Thoraval, F. et al. | 2017
- S21
-
Identifying residual risk of hepatocellular carcinoma following hepatitis C virus eradication in compensated cirrhosis: decision-tree and random forest models developed in the French multicenter prospective ANRS CO12 CirVir cohortAudureau, E. / Bourcier, V. / Layese, R. / Cagnot, C. / Marcellin, P. / Guyader, D. / Pol, S. / Larrey, D. / Roudot-Thoraval, F. / Nahon, P. et al. | 2017
- S22
-
Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide CohortInnes, H. / Barclay, S.T. / Hayes, P.C. / Fraser, A. / Dillon, J.F. / Stanley, A. / Bathgate, A. / McDonald, S. / Goldberg, D. / Valerio, H. et al. | 2017
- S23
-
Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antiviralsCalvaruso, V. / Cabibbo, G. / Cacciola, I. / Petta, S. / Madonia, S. / Bellia, A. / Stefano, M.D. / Giannitrapani, L. / Tinè, F. / Magro, A. et al. | 2017
- S24
-
Pharmacokinetics, safety and antiviral activity of CMX157, a novel prodrug of tenofovir, administered as ascending multiple doses to healthy volunteers and Hepatitis B virus-infected subjectsTanwandee, T. / Chatsiricharoenkul, S. / Thongsawat, S. / Sukeepaisarnjaroen, W. / Tangkijvanich, P. / Komolmit, P. / Avihingsanon, A. / Piratvisuth, T. / Sunthi, P. / Mahasanprasert, T. et al. | 2017
- S25
-
A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96Brunetto, M. / Lim, Y.S. / Gane, E. / Seto, W.K. / Osipenko, M. / Ahn, S.H. / Janssen, H.L. / Shukla, A. / Chuang, W.L. / Trinh, H. et al. | 2017
- S26
-
A phase1 study evaluating anti-PD-1 treatment with or without GS-4774 in HBeAg negative chronic hepatitis B patientsGane, E. / Gaggar, A. / Nguyen, A.H. / Subramanian, G.M. / McHutchison, J.G. / Schwabe, C. / Dunbar, R. et al. | 2017
- S27
-
Multiple dose study of GLS4JHS, interfering with the assembly of hepatitis B virus core particles, in patients infected with hepatitis B virusDing, Y. / Zhang, H. / Niu, J. / Chen, H. / Liu, C. / Li, X. / Wang, F. et al. | 2017
- S28
-
Modifications of virus-specific and total B cell populations by hepatitis B virus infectionSalimzadeh, L. / Bert, N.L. / Gill, U.S. / Kennedy, P.T. / Samuel, D. / Novikov, N. / Pflanz, S. / Frey, C.R. / Bertoletti, A. et al. | 2017
- S29
-
Hepatitis B virus-specific T cell receptors with high functional avidity redirect T cells to eliminate HBVWisskirchen, K. / Kah, J. / Metzger, K. / Weigand, L. / Uckert, W. / Schiemann, M. / Volz, T. / Krackhardt, A. / Dandri, M. / Protzer, U. et al. | 2017
- S33
-
A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 studyYurdaydin, C. / Idilman, R. / Keskin, O. / Kalkan, C. / Karakaya, M.F. / Caliskan, A. / Yurdcu, E. / Karatayli, S.C. / Bozdayi, M. / Koh, C. et al. | 2017
- S34
-
Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 studySangro, B. / Yau, T. / Hsu, C. / Kudo, M. / Crocenzi, T.S. / Choo, S.-P. / Meyer, T. / Welling, T.H. / Yeo, W. / Chopra, A. et al. | 2017
- S35
-
Mucosal-associated invariant T cells are significantly decreased and exhausted in patients with autoimmune liver disease, but promote primary hepatic stellate cell proliferationSchölzel, K. / Rombouts, K. / Rosselli, M. / Saffioti, F. / Roccarina, D. / Marshall, A. / Thorburn, D. / Pinzani, M. et al. | 2017
- S36
-
Inhibition of IL-1b/STAT3/β-catenin-dependent stimulation of the CXCL10/CXCR3 axis prevents macrophage recruitment and progression of the disease in Pkhd1del4/del4 mice, a model of congenital hepatic fibrosisKaffe, E. / Pellegrino, F. / Mariotti, V. / Fabris, L. / Cadamuro, M. / Amenduni, M. / Fiorotto, R. / Strazzabosco, M. / Spirli, C. et al. | 2017
- S37
-
C5a receptor blocking in TLR4 mutant C3H/HeJ mouse extensively hampers the liver regeneration processFaiyaz, R. / Mallard, B. / Muhamad, M. / Leonard, N. / Wheatley, A. et al. | 2017
- S39
-
Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European studyBelli, L.S. / Berenguer, M. / Cortesi, P.A. / Facchetti, R. / Strazzabosco, M. / Perricone, G. / Rockenschaub, S.-R. / Martini, S. / Morelli, C. / Donato, F. et al. | 2017
- S40
-
Changes in brain integrity underlying cognitive and functional recovery following liver transplantation plateaus after six monthsAhluwalia, V. / Wade, J. / Steinberg, J.L. / White, M. / Fagan, A. / Ganapathy, D. / Moeller, F.G. / Bajaj, J.S. et al. | 2017
- S42
-
Successful maintenance of direct converted hepatocyte–like cells by 3D bio printingWoo, J. / Choi, D. et al. | 2017
- S43
-
Visualizing hepatocellular amino acid kinetics through mass spectrometry imaging of stable isotopesArts, M. / Soons, Z. / Dubois, L.J. / Pierzchalski, K.A. / Ellis, S.R. / Balluff, B. / Eijkel, G.B. / Cramer, T. / Lieuwes, N. / Agten, S.M. et al. | 2017
- S44
-
The bile acid receptor TGR5 regulates paracellular permeability and protects the liver through an impact on the tight junction protein JAM-AMerlen, G. / Ursic-Bedoya, J. / Kahale, N. / Simerabet, H. / Doignon, I. / Tanfin, Z. / Péan, N. / Gautherot, J. / Ullmer, C. / Humbert, L. et al. | 2017
- S45
-
Hepatocyte polyploidy in response to loss of Cdk1 induces chronic hepatic inflammation and progenitor cell activationDewhurst, M. / Hul, N.V. / Caldez, M. / Kaldis, P. et al. | 2017
- S46
-
Simvastatin ameliorates the sinusoidal microcirculatory phenotype, fibrosis and portal hypertension in aged cirrhotic ratsMaeso-Diaz, R. / Ortega-Ribera, M. / Fernandez-Iglesias, A. / Muñoz, L. / Vila, S. / Albillos, A. / Garcia-Pagan, J.C. / Bosch, J. / Gracia-Sancho, J. et al. | 2017
- S47
-
Small-diameter covered stents do not affect efficacy but reduce hepatic encephalopathy in transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhosisWang, Q. / He, C. / Yin, Z. / Bai, M. / Wang, Z. / Guo, W. / Cai, H. / Xia, J. / Chen, H. / Lv, Y. et al. | 2017
- S48
-
Novel diameter controlled expansion TIPS (Viatorr CX®)graft reduces readmission compared to regular covered TIPS graft and bare metal graftPraktiknjo, M. / Lehmann, J. / Fischer, S. / Strassburg, C.P. / Meyer, C. / Trebicka, J. et al. | 2017
- S51
-
Treatment with selonsertib, an inhibitor of apoptosis signal-regulating kinase 1, hepatic phospho-p38 expression and markers of hepatocellular apoptosis and necrosis in patients with nonalcoholic steatohepatitisDiehl, A.M. / French, D. / Xu, R. / Loomba, R. / Lawitz, E. / Freilich, B. / Shiffman, M.L. / Chalasani, N. / Hameed, B. / Caldwell, S. et al. | 2017
- S53
-
Methylation signatures in blood show accelerated epigenetic aging in patients with non-alcoholic steatohepatitis compared to healthy controlsLoomba, R. / Gindin, Y. / Jiang, Z. / Lawitz, E. / Djedjos, C.S. / Caldwell, S. / Xu, R. / Gong, D. / Myers, R.P. / Subramanian, G.M. et al. | 2017
- S54
-
Real world experience with elbasvir/grazoprevir in the Veterans Affairs Healthcare SystemKramer, J.R. / Puenpatom, A. / Erickson, K. / Cao, Y. / El-Serag, H. / Kanwal, F. et al. | 2017
- S55
-
Sustained virological response for 94% of people treated with low-cost, legally imported generic direct acting antivirals for hepatitis C: analysis of 1087 patients in 4 treatment programmesFreeman, J. / Khwairakpam, G. / Dragunova, J. / Golovin, S. / Wang, J. / Hill, A. / Houghton-Price, V. / Smith, R. / Korologou-Linden, R. / Jefferys, G. et al. | 2017
- S56
-
Ledipasvir/sofosbuvir for 12 weeks is safe and effective in patients with chronic hepatitis C and hepatitis B coinfection: A phase 3 study in TaiwanLiu, C.-J. / Chuang, W.-L. / Sheen, I.-S. / Wang, H.-Y. / Chen, C.-Y. / Tseng, K.-C. / Chang, T.-T. / Massetto, B. / Yang, J. / Camus, G. et al. | 2017
- S56
-
Sofosbuvir plus daclatasvir for hepatitis C virus-cryoglobulinemia vasculitis (HCV-CryoVas): VASCUVALDIC 2 StudySaadoun, D. / Pol, S. / Ferfar, Y. / Hezode, C. / Ahmed, S.N.S. / Alric, L. / de Saint Martin, L. / Bouyer, A.S. / Musset, L. / Poynard, T. et al. | 2017
- S57
-
Ledipasvir/sofosbuvir ± ribavirin for 12 or 24 weeks is safe and effective in children 6–11 years old with chronic hepatitis C infectionMurray, K.F. / Balistreri, W. / Bansal, S. / Whitworth, S. / Evans, H. / Gonzalez-Peralta, R.P. / Wen, J. / Massetto, B. / Kersey, K. / Zhu, Y. et al. | 2017
- S58
-
Hepatitis E virus infection and acute non-traumatic neurological injury: an international prospective pilot studyWebb, G.W. / van Eijk, J.J.J. / Cintas, P. / Norton, B. / Madden, R.G. / Jones, C. / Hunter, J.G. / Devooght-Johnson, N. / Pique, J. / Woolson, K. et al. | 2017
- S59
-
RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus dispensable of interferon productionXu, L. / Wang, W. / Li, Y. / Zhou, X. / Yin, Y. / Wang, Y. / de Man, R.A. / Van Der Laan, L.J.W. / Huang, F. / Kamar, N. et al. | 2017
- S61
-
Blood-borne HEV transmission: first experience with global HEV screening at a tertiary centerWesthölter, D. / Hiller, J. / Denzer, U. / Peine, S. / Polywka, S. / Lohse, A.W. / Pischke, S. / Lütgehetmann, M. et al. | 2017
- S63
-
Gut microbiota are associated with impaired brain recovery after liver transplantBajaj, J.S. / Fagan, A. / Wade, J. / Gavis, E.A. / White, M. / Ganapathy, D. / Heuman, D. / Sikaroodi, M. / Fuchs, M. / John, B. et al. | 2017
- S64
-
The restoration of a healthy intestinal microbiota by fecal transplantation normalizes portal hypertension and endothelial dysfunction in a rat model of diet-induced non-alcoholic steatohepatitisGarcía-Lezana, T. / Martell, M. / Raurell, I. / Bravo, M. / Torres-Arauz, M. / Salcedo, M.T. / Manichanh, C. / Genescà, J. / Augustin, S. et al. | 2017
- S66
-
FibroScan-based score to identify patients with non-alcoholic steatohepatitis: development in a multi-centric British cohort and validation in a large American cohortSasso, M. / Harrison, S.A. / Eddowes, P.J. / Anstee, Q.M. / Guha, I.N. / Sherridan, D. / Tsochatzis, E. / Cobbold, J.F. / Allison, M. / Fournier, C. et al. | 2017
- S67
-
Reliability criteria for the diagnosis of fatty liver using controlled attenuation parameter by transient elastography – A multicentre study of 754 patientsWong, V.W.-S. / Petta, S. / Hiriart, J.-B. / Cammà, C. / Wong, G.L.-H. / Marra, F. / Vergniol, J. / Chan, A.W.-H. / Di Marco, V. / Merrouche, W. et al. | 2017
- S68
-
Simple non-invasive fibrosis scores identify patients with non-alcoholic fatty liver disease who progress to advanced fibrosis/cirrhosis:evidence from a large cohort of patients with sequential liver biopsiesMcpherson, S. / Pais, R. / Valenti, L. / Schattenberg, J.M. / Dufour, J.-F. / Tsochatzis, E. / Francque, S. / Hardy, T. / Boyle, M. / Tiniakos, D. et al. | 2017
- S69
-
Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) CohortBrandman, D. / Boyle, M. / McPherson, S. / Van Natta, M. / Sanyal, A. / Kowdley, K. / Tetri, B. / Chalassani, N. / Abdelmalek, M. / Terrault, N.A. et al. | 2017
- S70
-
Outcomes of treatment for hepatitis C virus infection in the prison settingMcDonald, L. / Cragie, A. / Schulberg, J. / Scarmozzino, J. / Papaluca, T. / Stoove, M. / Howell, J. / Doyle, J. / Iser, D. / Thompson, A. et al. | 2017
- S71
-
Treatment cascade of hepatitis B and C in general, migrant and Roma populationsTouloumi, G. / Karakosta, A. / Kaskafetou, S. / Petraki, I. / Anagnostou, O. / Gavana, M. / Papatheodoridis, G. / Kalpourtzi, A. / Mimikou, T. / Antypas, T. et al. | 2017
- S72
-
HIV/HCV-coinfected cirrhotic patients are no longer at higher risk of hepatocellular carcinoma or end-stage liver disease as compared to HCV-monoinfected patients (ANRS CO12 CirVir and ANRS CO13 HEPAVIH cohorts)Salmon, D. / Nahon, P. / Layese, R. / Bourcier, V. / Audureau, E. / Gilbert, C. / Esterle, L. / Dabis, F. / Wittkop, L. / Roudot-Thoraval, F. et al. | 2017
- S74
-
Molecular effects of the soluble guanylyl cyclase stimulator riociguat on biliary cirrhosis and effects on transaminases in patientsSchwabl, P. / Brusilovskaya, K. / Königshofer, P. / Supper, P. / Bauer, D. / Riedl, F. / Rohr-Udilova, N. / Hayden, H. / Aschauer, S. / Bonderman, D. et al. | 2017
- S75
-
The dual CCR2/CCR5 inhibitor Cenicriviroc ameliorates murine primary biliary cholangitisReuveni, D. / Leung, P. / Vig, P. / Shibolet, O. / Gershwin, E.M. / Zigmond, E. et al. | 2017
- S76
-
Development of novel epigenetic inhibitors for the treatment of hepatocellular carcinomaBárcena-Varela, M. / Oyarzabal, J. / Banales, J.M. / Prieto, J. / Alvarez-Asiain, L. / Prosper, F. / Berasain, C. / Avila, M.A. / Fernandez-Barrena, M.G. et al. | 2017
- S77
-
Hepatic LGR5 stem cells contribute to liver carcinogenesisCao, W. / Li, M. / Liu, P. / Liu, J. / Bolkestein, M. / Chen, K. / Van Der Laan, L.J.W. / Sprengers, D. / Metselaar, H.J. / Kwekkeboom, J. et al. | 2017
- S78
-
Diabetes augments obesity in accelerating liver tumour development: role of oxidative stress-induced JNK signalling and DNA damage responseArfianti, E. / Barn, V. / Pok, S. / Larter, C.Z. / Teoh, N.C. / Farrell, G.C. et al. | 2017
- S79
-
Efficacy of grannulocyte colony stimulating factor in the management of steroid non-responsive severe alcoholic hepatitis – A double blind randomised control trialShasthry, S.M. / Sharma, M. / Sarin, S. et al. | 2017
- S80
-
Comparison of cytokine profiles in idiosyncratic drug-induced liver injury, acute non-drug-induced hepatitis and controlsStephens, C. / Sanjuan-Jiménez, R. / Sanabria-Cabrera, J.A. / Battikhi, B. / Ortega-Alonso, A. / Robles-Díaz, M. / Jiménez-Pérez, M. / Medina-Cáliz, I. / Ruiz-Cabello, F. / Lucena, M.I. et al. | 2017
- S82
-
Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapiesDi Maio, V.C. / Cento, V. / Lenci, I. / Aragri, M. / Barbaliscia, S. / Francioso, S. / Paolucci, S. / Melis, M. / Verucchi, G. / Coppola, N. et al. | 2017
- S83
-
MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failurePoordad, F. / Pol, S. / Asatryan, A. / Buti, M. / Shaw, D. / Hézode, C. / Lalezari, J. / Felizarta, F. / Reindollar, R.W. / Gordon, S.C. et al. | 2017
- S84
-
Re-treatment of patients with decompensated chronic hepatitis C virus cirrhosis using 24 weeks of sofosbuvir and NS5A inhibitor, with or without ribavirin after failing a 12 week courseCheung, M.C. / Filipe, A. / Walker, A. / Mutimer, D.J. / Agarwal, K. / Aldersley, M. / MacDonald, D. / Khakoo, S. / McLauchlan, J. / Foster, G.R. et al. | 2017
- S85
-
SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinomaVilgrain, V. / Bouattour, M. / Sibert, A. / Lebtahi, R. / Ronot, M. / Pageaux, G.-P. / Guiu, B. / Barraud, H. / Silvain, C. / Gérolami, R. et al. | 2017
- S86
-
Etiology, time frame and spectrum of decompensation in 6236 patients of cirrhosis liver across Asia: a multinational study from APASL ACLF Research Consortium (AARC)Choudhury, A. / Sharma, M.K. / Sharma, B.C. / Maiwal, R. / Pamecha, V. / Moreau, R. / Chawla, Y.K. / Duseja, A. / Mahtab, M.A. / Rahman, S. et al. | 2017
- S87
-
Interaction between alcohol use and metabolic components in predicting severe liver disease in the general population – a decade follow-up of a nationally representative cohortÅberg, F. / Helenius-Hietala, J. / Puukka, P. / Färkkilä, M. / Jula, A. et al. | 2017
- S88
-
Safety and efficacy of besifovir in treatment-naïve chronic hepatitis B virus infection: a randomized, double-blind, double dummy, phase 3 studyAhn, S.H. / Kim, W. / Jung, Y.K. / Yang, J.M. / Jang, J.Y. / Kweon, Y.O. / Cho, Y.K. / Kim, Y.J. / Hong, G.Y. / Kim, D.J. et al. | 2017
- S89
-
BMS-986036 (pegylated FGF21) in patients with non-alcoholic steatohepatitis: a phase 2 studySanyal, A. / Charles, E.D. / Neuschwander-Tetri, B. / Loomba, R. / Harrison, S. / Abdelmalek, M. / Lawitz, E. / Halegoua-DeMarzio, D. / Dong, Y. / Noviello, S. et al. | 2017
- S90
-
MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infectionReau, N. / Kwo, P.Y. / Rhee, S. / Brown, R.S. / Agarwal, K. / Angus, P. / Gane, E. / Kao, J.-H. / Mantry, P.S. / Reddy, K.R. et al. | 2017
- S91
-
Controlled attenuation parameter as an additional tool for the non-invasive prediction of first clinical decompensation in compensated advanced chronic liver diseaseMargini, C. / Murgia, G. / Stirnimann, G. / De Gottardi, A. / Semmo, N. / Casu, S. / Bosch, J. / Dufour, J.-F. / Berzigotti, A. et al. | 2017
- S92
-
NGM282, a novel variant of FGF19, significantly reduces hepatic steatosis and key biomarkers of NASH: results of a Phase 2, multicenter, randomized, double-blinded, placebo controlled trial in biopsy-confirmed NASH patientsHarrison, S.A. / Abdelmalek, M.F. / Trotter, J.F. / Paredes, A.H. / Arnold, H.L. / Kugelmas, M. / Bashir, M.R. / Ling, L. / Rossi, S.J. / DePaoli, A.M. et al. | 2017
- S95
-
Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in EuropeMarshall, A.D. / Nielsen, S. / Cunningham, E.B. / Aghemo, A. / Alho, H. / Backmund, M. / Bruggmann, P. / Dalgard, O. / Flisiak, R. / Foster, G. et al. | 2017
- S96
-
One year follow-up and HBV RNA / HBcrAg analysis in the REP 301 Trial: REP 2139 and pegylated interferon alpha-2a in Caucasian patients with chronic HBV / HDV co-infectionBazinet, M. / Pantea, V. / Cebotarescu, V. / Cojuhari, L. / Jimbei, P. / Krawczyk, A. / Vaillant, A. et al. | 2017
- S97
-
Preventing decompensation of cirrhosis with clinically significant portal hypertension and without high-risk varices: a new indication for non-selective beta-blockers (NSBB)Villanueva, C. / Albillos, A. / Genescà, J. / Garcia-Pagan, J.C. / Calleja, J.L. / Aracil, C. / Bañares, R. / Morillas, R. / Poca, M. / Peñas, B. et al. | 2017
- S98
-
A Notch receptor-selective Jagged1 mutation causes an Alagille syndrome phenotype in miceAndersson, E.R. et al. | 2017
- S99
-
Establishing the foundation for a novel, first-in-class, fatty acid synthase inhibitor, TVB-2640, for the treatment of NASHDuke, G. / Wagman, A.S. / Buckley, D. / McCulloch, W. / Kemble, G. et al. | 2017
- S101
-
A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 studyKoh, C. / Surana, P. / Han, T. / Fryzek, N. / Kapuria, D. / Etzion, O. / Takyar, V. / Rotman, Y. / Canales, R. / Dahari, H. et al. | 2017
- S102
-
Efficacy and safety of Glecaprevir/Pibrentasvir in patients co-infected with hepatitis C virus and human immunodeficiency virus-1: the EXPEDITION-2 StudyRockstroh, J. / Lacombe, K. / Viani, R.M. / Orkin, C. / Wyles, D. / Luetkemeyer, A. / Soto-Malave, R. / Flisiak, R. / Bhagani, S. / Sherman, K.E. et al. | 2017
- S103
-
A reduction in the hepatic venous pressure gradient (HVPG) prevents clinical outcomes in compensated and decompensated cirrhosis: a meta-analysisTurco, L. / Villanueva, C. / La Mura, V. / Garcia-Pagan, J.C. / Reiberger, T. / Genesca, J. / Groszmann, R.J. / Sharma, B.C. / Merkel, C. / Bureau, C. et al. | 2017
- S104
-
Severe periodontitis predicts higher cirrhosis mortalityGrønkjær, L.L. / Holmstrup, P. / Schou, S. / Jepsen, P. / Vilstrup, H. et al. | 2017
- S106
-
Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adultsAlexander, M. / Loomis, K. / Fairburn-Beech, J. / van der Lei, J. / Duarte-Salles, T. / Ansell, D. / Pasqua, A. / Rijnbeek, P. / Avillach, P. / Kendrick, S. et al. | 2017
- S107
-
Worldwide lack of early referral of patients with alcoholic liver disease: results of the global alcoholic liver disease survey (GLADIS)Shah, N.D. / Cots, M.V. / Zhang, C. / Zahiragic, N. / Yu, Y. / Yacoub, M. / Wu, P. / Wandera, A. / Vorobioff, J. / Traquino, E.S.D.S. et al. | 2017
- S108
-
The roles of glycogen synthase kinase-3 genes in liver functionsPatel, P. / Patel, S. / Woodgett, J.R. et al. | 2017
- S109
-
Prospective prevalence study of adult NAFLD/NASH utilizing multi-modality imaging compared with liver bopsyHarrison, S.A. / Roberts, K.K. / Paredes, A.H. / Lisanti, C. / Schwope, R. / Cebe, K.M. / Whitehead, J.M.A. / Paradis, V. / Bedossa, P. / Aden, J.K. et al. | 2017
- S110
-
Next-Generation Sequencing (NGS) of two independent cohorts identifies eleven circulating miRNAs for diagnosis of NASH and fibrosisFrancque, S. / Cordonnier, G. / Texier, F. / Ratziu, V. / Harrison, S. / Bedossa, P. / Anstee, Q. / Roudot, A. / Megnien, S. / Hum, D. et al. | 2017
- S112
-
Propranolol versus endoscopic variceal ligation in patients with cirrhosis and ascites- a randomised controlled trialSingh, V. / Kumar, P. / Vijayvergia, R. / Bhalla, A. et al. | 2017
- S113
-
iPLA2beta protects aged male mice from liver fibrosis and intestinal atrophy by modulating phospholipid and enterohepatic bile acid metabolismJiao, L. / Gan-Schreier, H. / Zhu, X. / Wei, W. / Tuma-Kellner, S. / Liebisch, G. / Stremmel, W. / Chamulitrat, W. et al. | 2017
- S114
-
Ki67, cyclin D and caspase 3 allow distinction of two sub-groups of alcoholic patients at early stages of alcoholic liver diseaseStärkel, P. / Desaeger, C. / Lanthier, N. / Leclercq, I. et al. | 2017
- S116
-
Drinking behaviour and rs738409:G in PNPLA3 are associated with slower recovery of liver function following severe alcoholic hepatitisAtkinson, S.R. / Way, M.J. / McQuillin, A. / Morgan, M.Y. / Thursz, M.R. et al. | 2017
- S117
-
Hepatocyte but not macrophage-specific stard1 deletion attenuates alcoholic liver diseaseRibas, V. / Nuñez, S. / Garcia-Ruiz, C. / Fernandez-Checa, J. et al. | 2017
- S118
-
Risk factors of early emergent hospital readmission and 6-month mortality in patients with cirrhosis after a recovery from bacterial or fungal infectionMorando, F. / Piano, S. / Rosi, S. / Stanco, M. / Pilutti, C. / Vettore, E. / Romano, A. / Fasolato, S. / Tonon, M. / Brocca, A. et al. | 2017
- S119
-
Von Willebrand Factor as a predictor of short-term morbidity and mortality in comparison with conventional scoring systemsKulkarni, A.V. / Venkatkrishnan, L. / Krishnaveni, J. / Swaminathan, M. / Vegiraju, V. / Murthy, K. / Dharamsi, S. / Krishna, P. et al. | 2017
- S120
-
Rapid change of liver stiffness after variceal ligation and TIPS implantationPiecha, F. / Paech, D. / Sollors, J. / Seitz, H.-K. / Rössle, M. / Mueller, S. et al. | 2017
- S121
-
Outcome of liver transplant recipients after the first episode of bacterial infectionFerrarese, A. / Zanetto, A. / Germani, G. / Gambato, M. / Russo, F.P. / Cillo, U. / Angeli, P. / Burra, P. / Senzolo, M. et al. | 2017
- S122
-
Usefulness of the six-minute walk as a predictor of mortality in patients with decompensated cirrhosisGuillen, E.M. / Martinez, S.G.M. / Ávila, J.F.S. / Juarez, I.G. et al. | 2017
- S123
-
High serum human beta-defensin-1 is associated with increased short-term mortality in patients with decompensated cirrhosisAgiasotelli, D. / Alexopoulou, A. / Vasilieva, L. / Mani, I. / Hadziyannis, E. / Goukos, D. / Daikos, G.L. / Dourakis, S.P. et al. | 2017
- S124
-
Uncontrolled glycaemia increases the risk of developing spontaneous bacterial peritonitis in patients with cirrhosisServin-Caamaño, A.I. / Navarro-Estrada, A.E. / Pérez-Hernández, J.L. / de Guevara, V.L.-L. / Cruz-Estrada, A. / de La Tijera, F.H. et al. | 2017
- S125
-
Metabolic risk factors increase the risk of hepatocellular carcinoma in patients with hepatitis C cirrhosisKutsenko, A. / Le, A. / Trinh, S. / Dang, H. / Nguyen, M. et al. | 2017
- S126
-
C reactive protein contributes to the early prediction of 90-day mortality risk in acutely decompensated cirrhotic patientsClemente, A. / Romero, M. / Martínez, C. / Bueno, A. / Antona, M. / Salcedo, M. / Fernández, A. / Catalina, M.V. / Clemente, G. / Rincón, D. et al. | 2017
- S128
-
Prevalence of portal trombosis related to the degree of portal hypertensionPuente, A. / Fortea, J.I. / Ruiz, P. / Loste, M.T.A. / Cabezas, J. / Llerena, S. / Estebanez, A. / Fábrega, E. / Crespo, J. et al. | 2017
- S129
-
Long-term prognosis following acute-on-chronic liver failureYoon, E.L. / Kim, T.Y. / Song, D.S. / Kim, H.Y. / Kim, C.W. / Jung, Y.K. / Sinn, D.H. / Jang, J.Y. / Kim, M.Y. / Jeong, S.W. et al. | 2017
- S131
-
Resistant bacterial infections in cirrhosis: a French observational prospective multicentre nationwide study (RESIST study)Pauwels, A. / Meunier, L. / Boivineau, G. / Martin, T. / Touze, I. / Zuberbuhler, F. / Allaire, M. / Margos, W. / Carbonell, N. / Lambare, B. et al. | 2017
- S133
-
Bioelectrical impedance vector analysis is an objective method for nutritional assessment in patients with cirrhosisRuiz-Margáin, A. / Rodriguez, R.U.M. / Cuevas, A.E. / Cubero, F.J. / Trautwein, C. / Torre, A. et al. | 2017
- S134
-
Human ascites microfibril-associated protein 4 is an independent predictor of mortality in decompensated cirrhosisMadsen, B.S. / Kjærgaard, M. / Thiele, M. / Pohlmann, A. / Lutz, P. / Schierwagen, R. / Klein, S. / Jansen, C. / Lehmann, J. / Mortensen, C.O. et al. | 2017
- S136
-
Ethnic differences in overall survival of patients with cirrhosis: results of a cohort of 2939 United States patients with long-term follow-upZhao, C. / Nguyen, P. / Hoang, J.K. / Trinh, S. / Cho, C. / Yasukawa, L.A. / Weber, S. / Nguyen, M. et al. | 2017
- S137
-
Urinary MicroARNs as potential biomarkers to predict the evolution of kidney function after liver transplantation in patients with cirrhosisLejealle, C. / Roux, O. / Weiss, E. / Fasseu, M. / Moreau, R. / Durand, F. / Francoz, C. et al. | 2017
- S138
-
The impact of esophageal varices on the prognosis of patients with hepatocellular carcinoma after surgical resection: a propensity score matching analysisChang, C.-Y. / Su, C.-W. / Hsieh, W.-Y. / Chau, G.-Y. / Hou, M.-C. / Chen, P.-H. / Lee, P.-C. / Huo, T.-I. / Huang, Y.-H. / Lin, H.-C. et al. | 2017
- S139
-
Not all of the patients with hepatitis B-related hepatocellular carcinoma require endoscopic screening for esophageal varices: a large cohort studyChang, C.-Y. / Su, C.-W. / Chen, P.-H. / Hou, M.-C. / Lee, P.-C. / Lin, H.-C. / Huang, Y.-H. / Huo, T.-I. / Wu, J.-C. et al. | 2017
- S140
-
Bone marrow of cirrhotic patients displays features of myeloid biasnessBihari, C. / Lal, D. / Sharma, S. / Sukriti, S. / Bhadoria, A.S. / Rastogi, A. / Sarin, S.K. et al. | 2017
- S141
-
Polyunsaturated fatty acids and eicosanoids in ascites serve as potential new biomarkers for complications in liver cirrhosisEngelmann, C. / Degenhardt, V. / Dorow, J. / Krohn, S. / Herber, A. / Mueller, N. / Herta, T. / Thiery, J. / Ceglarek, U. / Berg, T. et al. | 2017
- S143
-
Low sensitivity to thrombomodulin in patients with cirrhosis; Impact of factor VIII increase and protein C deficiencyDuron, C. / Lebreton, A. / Sinegre, T. / Massoulier, S. / Muti, L. / Lamblin, G. / Pereira, B. / Berger, M. / Abergel, A. et al. | 2017
- S144
-
Impaired cerebral oxygenation, but preserved cerebrovascular reactivity, in an animal model of hepatic encephalopathyHadjihambi, A. / Hosford, P. / Davies, N. / Jalan, R. / Gourine, A. et al. | 2017
- S145
-
Extracellular vesicles induce renal tubular cells apoptosis, oxidative stress and functional abnormalities in patients with an acute decompensation of cirrhosisBrocca, A. / Medica, D. / Piano, S. / Romano, A. / Tonon, M. / Sticca, A. / Vincenzo, C. / Angeli, P. et al. | 2017
- S147
-
Osteoprotegerin is more than a serum marker in liver fibrosisAdhyatmika, A. / Beljaars, L. / Putri, K.S.S. / Reker-Smit, C. / Boorsma, C.E. / Guney, B. / Haak, A. / Post, E. / Poelstra, K. / Melgert, B.N. et al. | 2017
- S149
-
Use of non-invasive methods to assess hepatic steatosis and advanced fibrosis in type-1 diabetic patientsSingh, A. / Lopez, R. / Le, P. / Alkhouri, N. et al. | 2017
- S150
-
Validation of non-invasive fibrosis assessments in biopsy-proven non-alcoholic fatty liver diseaseDrolz, A. / Wehmeyer, M. / Diedrich, T. / zur Wiesch, J.S. / Lohse, A.W. / Kluwe, J. et al. | 2017
- S151
-
Pharmacokinetics of selonsertib, GS-9674, and/or GS-0976 in combination in healthy subjectsNelson, C.H. / Kirby, B.J. / Lu, N. / McColgan, B. / Djedjos, C.S. / Myers, R.P. / Cuvin, J. / Qin, A. / Mathias, A. et al. | 2017
- S152
-
Combination of long term N-Acetylcysteine and Ursodeoxycolic Acid in NASH: a multicenter randomized control trialOliveira, C.P. / Cotrim, H.P. / Cristina, A. / Siqueira, G. / Salgado, A.L.A. / Stefano, J.T. / Brizolla, P. / Mattos, L. / Martins, A.H.B. / Andrade, A.R. et al. | 2017
- S153
-
Autonomic function is impaired across the spectrum of NAFLDHoughton, D. / Zalewski, P. / Cassidy, S. / Thoma, C. / Hallsworth, K. / Avery, L. / Lukowska, A.B. / Hardy, T. / Burt, A.D. / Masson, S. et al. | 2017
- S155
-
Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLDGómez, E.V. / Aller, R. / Gallego-Durán, R. / Bañales, J. / Loste, M.T.A. / García-Monzón, C. / Ramirez, H.P. / García-Torres, M.L. / Gómez-Camarero, J. / Caballería, J. et al. | 2017
- S156
-
Automated, fully quantitative analysis by using second harmonic generation microscopy in the fibrosis progression of nonalcoholic fatty liver diseaseLiu, F. / Zhao, J.-M. / Liu, P.-H. / Rao, H.-Y. / Zhang, W. / Wu, N. / Wei, L. et al. | 2017
- S158
-
Presence of metabolic syndrome and low CD4 count are independently associated with liver fibrosis in human immunodeficiency virus-infected patients with non-alcoholic fatty liverPerazzo, H. / Cardoso, S.W. / Yanavich, C. / Munteanu, M. / Morata, M. / Simplicio, P. / Cardoso, C. / Almeida, C. / Poynard, T. / Veloso, V.G. et al. | 2017
- S159
-
Impact of modest weight reduction on liver histology, portal pressure, and clinical events in patients with compensated cirrhosis due to nonalcoholic steatohepatitisBosch, J. / Harrison, S. / Ratziu, V. / Shiffman, M. / Diehl, A. / Caldwell, S. / Rockey, D. / Ghalib, R. / Thuluvath, P. / Abdelmalek, M. et al. | 2017
- S160
-
A pragmatic algorithm to rule out Non-alcoholic steatohepatitis in patients at risk of non-alcoholic fatty liver disease in spite of a normal ultrasoundAmpuero, J. / Aller, R. / Gallego-Durán, R. / Bañales, J. / Loste, A. / Teresa, M. / García-Monzón, C. / Vilar-Gómez, E. / Escudero, A. / Gómez-Camarero, J. et al. | 2017
- S161
-
The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver diseaseBoursier, J. / Vergniol, J. / Lannes, A. / Hiriart, J.-B. / Oberti, F. / Le Bail, B. / Michalak, S. / Chermak, F. / Bertrais, S. / Foucher, J. et al. | 2017
- S162
-
Anti-fibrotic effect of NV556, a sanglifehrin-based cyclophilin inhibitor, in a preclinical model of non-alcoholic steatohepatitisGrönberg, A. / Elmér, E. / Gregory, M. / Moss, S. / Hansson, M. et al. | 2017
- S163
-
The immunomodulatory activity of the protease-inhibitor SerpinB3 in vivo and in vitroCappon, A. / Quarta, S. / Biasiolo, A. / Turato, C. / Villano, G. / Ruvoletto, M. / Sutti, S. / Bruzzi, S. / Novo, E. / Morello, E. et al. | 2017
- S164
-
CD40 activation alleviates steatosis in cultured hepatocytesChatzigeorgiou, A. / Baer, K. / Chavakis, T. et al. | 2017
- S166
-
The gut microbiome of lean patients with non-alcoholic steatohepatitis: comparison with overweight/obese counterparts and healthy subjects, correlation with dietary intake and liver histologyDuarte, S.M. / Stefano, J.T. / Miele, L. / Ponziani, F.R. / Souza, M. / Rodrigues, L. / Costa, F.G. / Toda, K. / Mazo, D.F. / Sabino, E.C. et al. | 2017
- S167
-
High fat diet related liver damage anticipates the appearance of cardiac injury: the role of Klf15 and tafazzinPorcu, C. / Barbaro, B. / Antonucci, L. / Viscomi, C. / Balsano, C. et al. | 2017
- S169
-
Hypoxia-inducible factor 2alpha drives the progression of experimental non-alcoholic fatty liver disease by stimulating hepatocyte production of histidine rich glycoproteinMorello, E. / Sutti, S. / Foglia, B. / Cannito, S. / Novo, E. / Bocca, C. / Bruzzì, S. / Bugianesi, E. / Albano, E. / Parola, M. et al. | 2017
- S171
-
Genotypic-phenotypic profile of Wilson disease patients in Lebanon: comparison with regional Arab countriesEl Haddad, A.K. / Usta, J. / Jomaa, M. / Katerji, M. / Barada, K. et al. | 2017
- S172
-
Age-dependent glycosylation of the sodium taurocholate co-transporte polypeptide: from neonates to adult human primary hepatocytesSargiacomo, C. / Najimi, M. / Sokal, E. et al. | 2017
- S176
-
Multi-center study of liver disease in alpha1-antitrypsin deficiency: non-invasive evaluation of liver fibrosis in homozygous PiZZ patientsHamesch, K. / Scholten, D. / Spivak, I. / Voss, J. / Bretag, T. / Wetzel, M. / Siegmund, B. / Reichert, M. / Bals, R. / Lammert, F. et al. | 2017
- S177
-
GANAB mutations: a possible lead to a common hepatic cystogenesis pathway in autosomal dominant polycystic kidney and liver disease?Van De Laarschot, L.F.M. / te Morsche, R.H. / Drenth, J.P.H. et al. | 2017
- S178
-
New molecular classification of hepatoblastoma through an integrative genomic and transcriptomic studySimon-Coma, M. / Akers, N. / Sia, D. / Royo, L. / Carrillo, J. / Pedersen, K. / Mallo, M. / Arnal, M. / Kuchuk, O. / Gambato, M. et al. | 2017
- S179
-
Variants in TM6SF2 and PCSK7 are risk factors for the development of cirrhosis in people with genetic haemochromatosisBuch, S. / Way, M.J. / Stickel, F. / Ryan, E. / Zoller, H. / Griffiths, W.J.H. / McQuillin, A. / Zwerina, J. / Ryan, J.D. / Gallati, S. et al. | 2017
- S180
-
Antibiotics induce remission in pediatric PSC-AIH overlap syndrome allowing corticosteroid-free therapySambon, P. / Varma, S. / Komuta, M. / Clapuyt, P. / Sokal, E. et al. | 2017
- S181
-
GMP-level isolation, quality assessment and biosafety distribution evaluation on human amnion epithelial cell for cell-based therapiesGramignoli, R. / Srinivasan, R.C. / Kristina, K. / Askelof, U. / Zabulica, M. / Strom, S.C. et al. | 2017
- S182
-
Fontan-associated liver disease: diagnosis by elastography and laparoscopic liver biopsyKoizumi, Y. / Hirooka, M. / Yukimoto, A. / Imai, Y. / Nakamura, Y. / Watanabe, T. / Yoshida, O. / Tokumoto, Y. / Higaki, T. / Abe, M. et al. | 2017
- S183
-
Early treatment of HCV-recurrent infection post liver transplantation in the era of the new direct acting antivirals, what we learned till now?Sakr, M.A. / Dabbous, H.M. / Montasser, I.F. / Ebada, H.E. / Abdelhafeez, K.A. / Massoud, Y.M. / Bahaa, M.M. / Elmeteini, M.S. et al. | 2017
- S184
-
No increase in graft fibrosis for hepatitis B surface antigen positive patients after liver transplantation using entecavir monotherapyFung, J.Y.Y. / Wong, T. / Chok, K. / Chan, A. / Sin, S.-L. / Ng, K. / Cheung, T.-T. / Dai, J. / Seto, W.-K. / Lai, C.-L. et al. | 2017
- S185
-
Progression of familial amyloidosis after domino liver transplantation in donor and recipientVollmar, J. / Schmid, J.C. / Hoppe-Lotichius, M. / Emrich, T. / Geber, C. / Schad, A. / Mittler, J. / Lang, H. / Galle, P.R. / Zimmermann, T. et al. | 2017
- S186
-
Donor mannose-binding lectingene polymorphisms increase the risk of severe bacterial infections after liver transplantationLombardo, J. / Sanclemente, G. / Colmenero, J. / Español, M. / Arias, M.T. / Ruiz, P. / Mauro, E. / Sastre, L. / Crespo, G. / Moreno, A. et al. | 2017
- S187
-
Occult hepatitis B virus persistence in liver transplant recipients despite prophylactic hepatitis B immune globulin and potent nucleos/tide analogues therapyLau, K.C. / Osiowy, C. / Giles, E. / van Marle, G. / Burak, K.W. / Coffin, C.S. et al. | 2017
- S189
-
The golden hour: length of total warm ischemia time presages development of severe acute kidney injury after DCD liver transplantationKalisvaart, M. / Umbro, I. / de Haan, J. / Scalera, I. / Schlegel, A. / IJzermans, J. / Perera, T. / Isaac, J. / Mitterhofer, A.P. / Muiesan, P. et al. | 2017
- S190
-
Entecavir or tenofovir monotherapy prevents hepatitis B virus recurrence in liver transplant recipients: a 5-year follow-up study after hepatitis B immunoglobulin withdrawalManini, M.A. / Bruce, M. / Whitehouse, G. / Carey, I. / Wang, B. / Gonsalkorala, E. / Considine, A. / Heneghan, M. / Lampertico, P. / Agarwal, K. et al. | 2017
- S191
-
Differences in the occurrence of metabolic syndrome between patients treated with a calcineurin inhibitor and patients treated with an mTOR inhibitor after liver transplantationTer Avest, M.M. / Guichelaar, M.M. / Brusse-Keizer, M.G. / Heinzow, H.S. / Schmidt, H.H. et al. | 2017
- S192
-
The association of the metabolic syndrome with cardiovascular and cerebrovascular outcomes and renal dysfunction after liver transplantationHo, O.F. / Lipka, G.M. / David, M.C. / Macdonald, G.A. et al. | 2017
- S194
-
History of marijuana use does not affect outcomes on the liver transplant waitlistKotwani, P. / Saxena, V. / Dodge, J. / Roberts, J. / Yao, F. / Hameed, B. et al. | 2017
- S196
-
MELD score >19 on day five after liver transplant in hepatitis C virus-positive recipients: impact on 90-day graft loss and analysis of predictorsMartini, S. / Tandoi, F. / di Bergamo, L.T. / Strona, S. / Sacco, M. / Maione, F. / Gonella, F. / Salizzoni, M. / Saracco, G.M. / Romagnoli, R. et al. | 2017
- S197
-
Evolution of body weight parameters up to 3 years after liver transplantation: the prospective Swiss transplant cohort studyBeckmann, S. / Dutkowski, P. / Nikolic, N. / Denhaerynck, K. / Binet, I. / Koller, M. / Boely, E. / De Geest, S. et al. | 2017
- S198
-
The risk of death after liver transplantation due to increasing donor age is highest in young recipientsBittermann, T. / Goldberg, D.S. et al. | 2017
- S200
-
A glycomic serum marker analysed at one week after liver transplantation is an independent predictor of graft loss during the first year after liver transplantationVerhelst, X. / Geerts, A. / Rogiers, X. / Vanlander, A. / Berrevoet, F. / Callewaert, N. / Troisi, R.I. / Van Vlierberghe, H. et al. | 2017
- S201
-
Inhibition of NADPH oxidase-2 and P38 mitogen activated protein kinase suppresses acrolein aggravated hepatic ischemia reperfusion injury through neutrophil extracellular trapsSuyavaran, A. / Thirunavukkarasu, C. et al. | 2017
- S202
-
Herpesviruses in bile: increasing sensitivity by testing the right compartmentRauber, C. / Bartelheimer, K. / Gotthardt, D. et al. | 2017
- S203
-
Approaches to fabricate practical recellularized liver graft using primary liver cells-our seeding method for optimal distribution of parenchymal and endothelial cellsKojima, H. / Yasuchika, K. / Fukumitsu, K. / Ishii, T. / Ogiso, S. / Miyauchi, Y. / Yamaoka, R. / Kawai, T. / Katayama, H. / Yoshitoshi, E. et al. | 2017
- S204
-
Correlation of efficacy and safety outcomes with regorafenib exposure in patients with hepatocellular carcinomaCleton, A. / Graudenz, K. / Huang, F. / Fiala-Buskies, S. / Ploeger, B. / Schlief, S. / Bonata, P. / Meinhardt, G. et al. | 2017
- S205
-
The systemic inflammatory response is a prognostic marker in human immunodeficiency virus-infected patients with hepatocellular carcinomaPinato, D.J. / Merli, M. / Pria, A.D. / Jamshaid, S. / Parker, K. / Pagani, N. / Hasson, H. / Uberti-Foppa, C. / Messina, E. / Sharma, R. et al. | 2017
- S207
-
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaArbelaiz, A. / Azkargorta, M. / Santos-Laso, Á. / Perugorria, M.J. / Erice, O. / Gonzalez, E. / Lapitz, A. / Izquierdo, L. / Olaizola, P. / Lee, P.Y. et al. | 2017
- S208
-
CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodulesTerzi, E. / De Bonis, L. / Leoni, S. / Benevento, F. / Granito, A. / Tovoli, F. / Pini, P. / Bolondi, L. / Piscaglia, F. et al. | 2017
- S209
-
Serum Markers for early diagnosis of hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virological response to direct-acting antivirals treatmentSangiovanni, A. / D’Ambrosio, R. / Lunghi, G. / Bruccoleri, M. / Alimenti, E. / Borghi, M. / Perbellini, R. / Aghemo, A. / Iavarone, M. / Colombo, M. et al. | 2017
- S210
-
Interferon-free therapy of chronic hepatitis C does not change the short-term risk for de novo hepatocellular carcinomas in patients with liver cirrhosisMettke, F. / Schlevogt, B. / Deterding, K. / Wranke, A. / Port, K. / Manns, M.P. / Vogel, A. / Cornberg, M. / Wedemeyer, H. et al. | 2017
- S212
-
Predictors for successful downstaging in patients with BCLC intermediate stage hepatocellular carcinomaBroekhoven, A. / Takkenberg, B. / Sprengers, D. / Ramsoekh, S. / van Erpecum, K. / van Meer, S. / Verspaget, H. / Burgmans, M. / Osanto, S. / Baranski, A. et al. | 2017
- S213
-
Portal vein infiltration in patients with hepatocellular carcinoma: the impact of correct classificationKloeckner, R. / Steinle, V. / Koch, S. / Dos Santos, D.P. / Marquardt, J. / Sprinzl, M. / Lang, H. / Dueber, C. / Galle, P. / Woerns, M. et al. | 2017
- S214
-
The effect of antiviral treatment on hepatitis B virus reactivation after radiotherapy for hepatocellular carcinomaJun, B.G. / Kim, Y.D. / Cheon, G.J. / Kim, S.G. / Kim, Y.S. / Jeong, S.W. / Jang, J.Y. / Lee, S.H. / Kim, H.S. et al. | 2017
- S215
-
Operability of perihilar cholangiocellular carcinoma can be reliably predicted by combination of endoscopic retrograde cholangiography, endoscopic ultrasound and computer tomography as variables in the European staging systemSchlevogt, B. / Kammerer, S. / Lessing, M. / Domagk, D. / Hüsing-Kabar, A. / Kabar, I. / Schmidt, H.H.-J. / Wolters, H. / Meister, T. / Heinzow, H.S. et al. | 2017
- S217
-
Clinical features of hepatocellular carcinoma in the elderly in a hepatitis B endemic country – a comparative study of 1430 casesCheah, C.-C.M. / Goh, B.-B.G. / Chang, P.-E. / Tan, C.-K. et al. | 2017
- S218
-
Hepatocellular carcinoma and rheumatoid arthritis: a 10-year population-based propensity-score matched cohort study in TaiwanHsu, C.-S. / Lang, H.-C. / Huang, K.-Y. / Chen, C.-L. et al. | 2017
- S219
-
The malignant transformation of hepatocellular adenoma: experience of a French liver centerSempoux, C. / Blanc, J.F. / Le Bail, B. / Chiche, L. / Balabaud, C. / Bioulac-Sage, P. et al. | 2017
- S220
-
Hepatocellular carcinoma diagnostic performance of liver imaging reporting and data system for contrast enhanced ultrasound and of quantitative contrast enhanced ultrasoundCristea, C.G. / Sandulescu, L.D. / Saftoiu, A. / Cazacu, S.M. / Gheonea, I.A. / Ciurea, T. et al. | 2017
- S222
-
Phase 3 biomarker study for HCC surveillance using AFP, AFP L-3 and DCP. A prospective collection with retrospective blinded evaluationEl-Serag, H. / White, D. / Tayob, N. / Alsarraj, A. / Mori, Y. / Yamada, H. / Kanwal, F. et al. | 2017
- S223
-
Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational studyYen, C. / Sharma, R. / Rimassa, L. / Arizumi, T. / Bettinger, D. / Evans, J. / Pressiani, T. / Burlone, M.E. / Pirisi, M. / Giordano, L. et al. | 2017
- S225
-
Role of RAS-dependent signaling pathways in hepatic carcinogenesisLechler, C. / Roesner, T. / Kohnke-Ertel, B. / Saur, D. / Sage, J. / Schmid, R.M. / Ehmer, U. et al. | 2017
- S226
-
Inhibition of lymph node metastasis by CTGF in Notch1 driven malignant transformation of rat liver oval cellsShi, X.-D. / He, S.-P. / Wu, W.-R. / Fu, H.-W. / Zhang, R. / Xu, L.-B. / Yu, X.-H. / Zeng, H. / Liu, C. et al. | 2017
- S227
-
Functional role of CCL5/RANTES for hepatocellular carcinoma progression during chronic liver diseaseMohs, A. / Kuttkat, N. / Reißing, J. / Zimmermann, H.W. / Sonntag, R. / Youssef, S.A. / de Bruin, A. / Cubero, F.J. / Trautwein, C. et al. | 2017
- S228
-
Proteomic analysis identifies argininosuccinate synthase 1 as a useful biomarker for hepatocellular adenoma classification and patient managementAbouhammoud, A. / Henriet, E. / Dupuy, J.-W. / Dartigues, B. / Ezzoukhry, Z. / Senant, N. / Blanc, J.-F. / Lebail, B. / Nikolski, M. / Bioulac-Sage, P. et al. | 2017
- S229
-
Cerium oxide nanoparticles display anti-tumoral activity and improve survival in experimental hepatocellular carcinomaFernandez-Varo, G. / Oró, D. / Yudina, T. / Carvajal, S. / Marfà, S. / Boix, L. / Perramón, M. / Oller, L. / Casals, G. / Morales-Ruiz, M. et al. | 2017
- S230
-
A new in vitro hepatocellular carcinoma model based on human normal and fibrotic 3D extracellular matrix scaffold bio-engineeringTelese, A. / Mazza, G. / Longato, L. / Al-Akkad, W. / Frenguelli, L. / Marrone, G. / Tamburrino, D. / Spoletini, G. / Hall, A. / Luong, T.V. et al. | 2017
- S231
-
microRNA-34a and natural killer cells: an immuno-epigenetic approach to halt hepatocellular carcinoma progressionAbdelhamid, A.K. / Yacoub, R.A. / Fawzy, I.O. / Gomaa, A. / Hosny, K. / Hamza, M.T. / Esmat, G. / Waked, I. / Abdelaziz, A.I. et al. | 2017
- S231
-
Chronic treatment with over-the-counter H1 or H2 histamine receptor blockers decreases cholangiocarcinoma xenograft tumor growth, angiogenesis and EMTHargrove, L. / Kennedy, L. / Demieville, J. / Francis, H. et al. | 2017
- S232
-
The impact of bariatric surgery on nonalcoholic fatty liver disease and cardiovascular risk utilizing non-invasive measuresNetanel, C. / Goitein, D. / Rubin, M. / Shechter, M. / Kleinbaum, Y. / Katsherginsky, S. / Hermon, H. / Hemi, R. / Tsaraf, K. / Donuzi, A. et al. | 2017
- S233
-
Noninvasive diagnosis of hepatic fibrosis by biofibroscore® in patients with chronic hepatitis C virus infectionLiu, C.-H. / Liu, C.-J. / Su, T.-H. / Yang, H.-C. / Kao, J.-H. / Chen, D.-S. / Chen, P.-J. et al. | 2017
- S234
-
Variability of intrahepatic fat distribution and optimal measurement of hepatic fat amount using MRI proton density fat fractionJun, D.W. / Ahn, S.B. / Saeed, W.K. / Oh, H.W. / Jeong, J.Y. / Sohn, J.H. / Jang, E.C. / Kang, B.-K. et al. | 2017
- S235
-
The role of serial ARFI elastography in confirming remission in active autoimmune liver disease: a controlled study with long follow upSherman, D.I. / Gandy, N. / Lung, P. / Tadrous, P. / Bassett, P. / Shorvon, P. et al. | 2017
- S236
-
Urinary metabotypes in patients with chronic hepatitis C virus infection as revealed by nuclear magnetic resonance-based metabolomicsBiliotti, E. / Tomassini, A. / Palazzo, D. / Capuani, G. / Sciubba, F. / Esvan, R. / De Angelis, M. / Franchi, C. / Iaiani, G. / Maida, P. et al. | 2017
- S238
-
Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimensRavaioli, F. / Marasco, G. / Reggiani, M.L.B. / Mazzella, G. / Buonfiglioli, F. / Porro, A. / Brillanti, S. / Colecchia, A. / Festi, D. et al. | 2017
- S239
-
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patientsRavaioli, F. / Mazzella, G. / Andreone, P. / Conti, F. / Brillanti, S. / Buonfiglioli, F. / Serio, I. / Verucchi, G. / Reggiani, M.L.B. / Marasco, G. et al. | 2017
- S240
-
Non-invasive assessment of liver fibrosis by point share wave elastography in primary biliary cholangitis: comparison with fibroscan® and fibrosis scoresSaffioti, F. / Rosselli, M. / Roccarina, D. / Pinzani, M. / Marshall, A. / Thorburn, D. et al. | 2017
- S241
-
Assessment of fibrosis markers in a large cohort of chronic hepatitis B patients in EthiopiaDesalegn, H. / Aberra, H. / Berhe, N. / Gundersen, S.G. / Johannessen, A. et al. | 2017
- S242
-
Characterisation of liver fat in the UK biobank cohortWilman, H.R. / Kelly, M. / Jandor, A. / Bell, J. / Banerjee, R. / Thomas, L. et al. | 2017
- S243
-
Novel mapping of fibrosis and hepatic inflammation in NASH patients with dual R2 MRI relaxometryFilho, H.M.L. / Chua-anusorn, W. / Oliveira, C.P. / Carrilho, F.J. / Lima, F. / Alves, V. / Clark, P. / Rocha, M. et al. | 2017
- S244
-
Hepatic iron overload analysis bymagnetic resonance imaging in a non-alcoholic fatty liver disease populationFilho, H.M.L. / Fabrega, P. / Chua-anusorn, W. / Oliveira, C.P. / Carrilho, F.J. / Lima, F. / Cercato, C. / Clark, P. / Rocha, M. et al. | 2017
- S246
-
Common polymorphisms in the TLR3 gene are stronger associated with spontaneous clearance of Hepatitis B virus infection in caucasians than variants of the HLA geneFischer, J. / Koukoulioti, E. / Schott, E. / Fueloup, B. / Heyne, R. / Berg, T. / van Bömmel, F. et al. | 2017
- S247
-
Serum hepatitis B core antibody as a novel tool to assess hepatic inflammation guide antiviral decision-making in chronic hepatitis B patients with normal alanine aminotransferase levelsZhou, J. / Zhao, H. / Yan, L. / Wang, G. et al. | 2017
- S248
-
Summary of the FDA report: twenty four hepatitis B reactivation cases during hepatitis C direct acting antiviral therapyBhamidimarri, K.R. / Widjaja, D. / Satapathy, S. / O’Brien, C. / Martin, P. et al. | 2017
- S249
-
A nationwide seroprevalence of hepatitis a in Republic of Korea from 2005 to 2014, before and after peak outbreak in 2009Jeong, S.-H. / Kim, K.-A. / Lee, A. / Ki, M. / Yoon, C.J. et al. | 2017
- S250
-
Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNAColagrossi, L. / Salpini, R. / Scutari, R. / Battisti, A. / Piermatteo, L. / Bertoli, A. / Menichini, C. / Trimoulet, P. / Fleury, H. / Nebuloso, E. et al. | 2017
- S251
-
Absence of hepatitis B reactivation among veterans with serological evidence of previous hepatitis B infection receiving anti-hepatitis C direct acting antiviralsTang, L. / Tolaymat, M. / Stonesifer, E. / Kottilil, S. / Wilson, E. et al. | 2017
- S252
-
Prevalence, determinants of chronic hepatitis B infection and hepatitis B genotypes in multi-ethnic SurinameMac Donald-Ottevanger, M.S. / van de Laar, T. / Zijlmans, W. / Prins, M. / Brinkman, K. / Roosblad, J. / Codrington, J. / van der Helm, J. / Vreden, S. et al. | 2017
- S253
-
Serum hepatitis B virus RNA level is associated with hepatitis B virus genotype and BCP mutations in untreated patients with HBeAg positive chronic hepatitis Bvan Campenhout, M.J. / van Bömmel, F. / Grossmann, M. / Fischer, J. / Deichsel, D. / Boonstra, A. / van Vuuren, A.J. / Berg, T. / Hansen, B.E. / Janssen, H.L. et al. | 2017
- S254
-
Clinical and virological outcomes of hepatitis B virus inactive carriers and gray zone patients: a comparative analysis using current EASL and AASLD Guidelines criteriaBonacci, M.S. / Lens, S. / Mariño, Z. / Lodoño, M.C. / del Pulgar, S.P. / Costa, J. / Sanchez-Tapias, J.M. / Forns, X. et al. | 2017
- S255
-
Outcome in chronic hepatitis delta: differences between African and non-African patientsSpaan, M. / Carey, I. / Wang, B. / Shang, D. / Horner, M. / Bruce, M. / Dusheiko, G. / Agarwal, K. et al. | 2017
- S256
-
Update on safety and efficacy in the REP 401 protocol: REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated Interferon alpha-2a in treatment naïve caucasian patients with chronic HBeAg negative HBV infectionBazinet, M. / Pantea, V. / Placinta, G. / Moscalu, I. / Cebotarescu, V. / Cojuhari, L. / Jimbei, P. / Iarovoi, L. / Smesnoi, V. / Musteata, T. et al. | 2017
- S257
-
Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International networkWranke, A. / Hardtke, S. / Borzacov, L.M.P. / Parana, R. / Lobato, C. / Hamid, S. / Ceausu, E. / Dalekos, G.N. / Rizzetto, M. / Turcanu, A. et al. | 2017
- S258
-
Viral kinetics in women of child bearing potential with chronic hepatitis B virus following treatment with tenofovir alafenamide or tenofovir disoproxil fumaratePan, C. / Chang, T.-T. / Bae, S.-H. / Brunetto, M. / Coffin, C. / Lau, A. / Mo, S. / Flaherty, J.F. / Gaggar, A. / Subramanian, G.M. et al. | 2017
- S259
-
On-treatment decline in HBeAg level at week 24 predicts for HBeAg seroconversion during long-term tenofovir therapy for HBeAg-positive CHBWong, D. / Littlejohn, M. / Yuen, L. / Jackson, K. / Mason, H. / Gaggar, A. / Kitrinos, K. / Subramanian, M. / Marcellin, P. / Buti, M. et al. | 2017
- S261
-
Hepatitis B virus basal core promotor variants become selected in serum hepatitis B virus DNA but not in hepatitis B virus RNA genome in patients responding to treatment with peginterferon-alfa 2a (PEG-IFNα)Grossmann, M. / Deichsel, D. / Pavlovic, V. / He, H. / Wat, C. / Hahn, C. / Berg, T. / Van Boemmel, F. et al. | 2017
- S262
-
Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technologyCaviglia, G.P. / Abate, M.L. / Olivero, A. / Rosso, C. / Ciancio, A. / Bugianesi, E. / Saracco, G.M. / Smedile, A. et al. | 2017
- S263
-
Experiences from one of the largest treatment programs for chronic hepatitis B in sub-Saharan AfricaDesalegn, H. / Aberra, H. / Berhe, N. / Gundersen, S.G. / Johannessen, A. et al. | 2017
- S265
-
Dissociation of temporal trends in mortality from liver disease and liver cancer in a hepatitis B virus-endemic population: 1999–2013Choi, J. / Han, S. / Kim, N. / Lim, Y.-S. et al. | 2017
- S266
-
Rising healthcare utilization and cost of chronic hepatitis B: real-world analysis of 44,026 chronic hepatitis B patients and 121,568 matched non-chronic hepatitis B controls in the United StatesLim, J. / Nguyen, M. / Liou, I. / Ozbay, A.B. / Moore-Schiltz, L. / Dusheiko, G. / Gordon, S. et al. | 2017
- S267
-
Change in the trajectory of MELD scores in liver transplant candidates with hepatitis C in the direct acting antiviral eraKwong, A. / Mannalithara, A. / Kim, D. / Kim, W.R. et al. | 2017
- S268
-
Declining prevalence and increasing awareness of hepatitis C virus infection in Italy: a population-based surveyAndriulli, A. / Stroffolini, T. / Valvano, M.R. / Grattagliano, I. / Ippolito, A.M. / Grossi, A. / Brancaccio, G. / Coco, C. / Russello, M. / Smedile, A. et al. | 2017
- S269
-
High-risk behaviour in a cohort of HIV/hepatitis C coinfected gay and bisexual men commencing hepatitis C treatmentBowing, A.L. / Doyle, J.S. / Iser, D.M. / Sasadeusz, J. / Roney, J. / O’Reilly, M. / Fairley, C. / Gane, E. / Hoy, J. / Matthews, G.V. et al. | 2017
- S270
-
Low hepatitis C virus prevalence among human immunodeficiency virus+ individuals in Sub-Saharan AfricaLoarec, A. / Molfino, L. / Walter, K. / Muyindike, W. / Carnimeo, V. / Andrieux-Meyer, I. / Balkan, S. / Nzomukunda, Y. / Maman, D. / Mwanga-Amumpaire, J. et al. | 2017
- S271
-
An audit of hepatitis C screening and referral patterns to a specialist hepatology service in a secondary care facility in the UKShearer, J. / Pratt, A. / Hutchinson, J. / Todd, N. / Millson, C. et al. | 2017
- S272
-
High incidence of persistently altered liver tests after sustained virological response with direct-acting antiviral in hepatitis C monoinfected and HIV-coinfected patientsMontes, M. / Domínguez, L. / Castillo, P. / García-Samaniego, J. / Martín-Carbonero, L. / Valencia, E. / Moreno, V. / Larrubia, J.R. / Romero, M. / García, A. et al. | 2017
- S273
-
Large-scale screening is not useful to identify individuals with hepatitis B or C virus infection: results of an interim analysisMarot, A. / Trabelsi, A. / André, C. / Deltenre, P. et al. | 2017
- S275
-
The number of small low-density lipoprotein particles is decreased by hepatitis C virus G1b infectionKinoshita, C. / Nagano, T. / Seki, N. / Hokari, A. / Aizawa, Y. et al. | 2017
- S276
-
Characterisation of resistance associated substitutions in direct acting antivirals treatment naive patients with genotype 3 hepatitis C virusSmith, D.A. / Magri, A. / Bonsall, D. / Ansari, M.A. / Ip, C. / Trebes, A. / Brown, A. / Piazza, P. / Bowden, R. / Klenerman, P. et al. | 2017
- S277
-
Understanding factors associated with hepatitis c spontaneous viral clearance: a meta-analysisAisyah, D.N. / Shallcross, L. / Hully, A.J. / Hayward, A. et al. | 2017
- S278
-
Rate and predictive factors of spontaneous hepatitis C virus clearance after acute infection in human immunodeficiency virus-positive subjectsMerli, M. / Galli, L. / Poli, A. / Salpietro, S. / Messina, E. / Parisi, M.R. / Andolina, A. / Morsica, G. / Bagaglio, S. / Castagna, A. et al. | 2017
- S279
-
Performance of the validated EGCRISC screening tool in chronic hepatitis C infection detection after application in the Egyptian settingEl-Ghitany, E.M. / Farghaly, A. / Farag, S. et al. | 2017
- S280
-
Factors that influence the improvement of serum albumin during interferon-free sofosbuvir/ledipasvir therapy for Japanese patients with chronic hepatitis C virus infectionKawano, A. / Ogawa, E. / Furusyo, N. / Nomura, H. / Dohmen, K. / Higashi, N. / Takahashi, K. / Azuma, K. / Satoh, T. / Nakamuta, M. et al. | 2017
- S281
-
Impact of IL28B genotype on response rates in hepatitis C virus cirrhotic patients treated with new DAA regimens: experience of a single centerPonzo, P. / Troshina, G. / Tucci, A. / Venezia, L. / Sacco, M. / Smedile, A. / Abate, M.L. / Caviglia, G. / Olivero, A. / Rizzetto, M. et al. | 2017
- S282
-
Risk of cardiovascular and cerebrovascular events in hepatitis C patients following completion of direct-acting antiviral therapy: a retrospective cohort studySinger, A.W. / Osinusi, A. / Brainard, D.M. / Chokkalingam, A.P. et al. | 2017
- S283
-
SVR reduces ethnic disparities in progression to advanced liver disease in patients with chronic hepatitis CLe, A.K. / Zhao, C. / Hoang, J. / Yasukawa, L.A. / Zhang, J. / Weber, S.C. / Nguyen, M. et al. | 2017
- S284
-
Efficacy and safety of paritaprevir/ritonavir, ombitasvir and dasabuvir plus/minus ribavirin for treatment of hepatitis C virus genotype 1b compensated cirrhosis in patients aged 70 years or olderTrifan, A. / Prelipcean, C.C. / Gheorghe, L. / Curescu, M.G. / Brisc, C. / Bataga, S. / Miftode, E. / Arama, V. / Chiriac, S.A. / Cuciureanu, T. et al. | 2017
- S286
-
Liver stiffness evaluated by means of ARFI is related not only to fibrosis in patients with hepatitis C virus-related chronic hepatitisGesualdo, A. / D’Alitto, F. / Ricci, L. / Di Gennaro, C. / Settimo, E. / Palmieri, V.O. et al. | 2017
- S289
-
High sustained virological response rates in hepatitis C genotypes 1a and 4 patients treated with elbasvir and grazoprevir and basal viremia >800.000 UI/mLOlveira, A. / Montes, M. / Navas, A.L. / García-Samaniego, J. / Martín-Carbonero, L. / Larrubia, J.R. / Castillo, P. / Madejón, A. / Romero, M. / García, A. et al. | 2017
- S290
-
The effect of directly acting antivirals treatment on inflammatory status in HCV-infected patients, including those with recurrence of HCV-infection after liver transplantation: preliminary results of a prospective monocentric pilot studyLattanzi, B. / Baroncelli, S. / Palmisano, L. / Galluzzo, C.M. / Michelini, Z. / Lupo, M. / De Santis, A. / Corradini, S.G. / Mennini, G. / Rossi, M. et al. | 2017
- S291
-
The path towards hepatitis C elimination in Australia following universal access to interferon-free treatmentsHajarizadeh, B. / Grebely, J. / Matthews, G.V. / Martinello, M. / Dore, G.J. et al. | 2017
- S292
-
Grazoprevir-elbasvir based therapy is safe and effective in patients with chronic kidney disease GFR < 30 and patients with end stage renal disease who are on renal replacement therapy in a community based settingYanny, B. / Sahota, A. et al. | 2017
- S293
-
Using all-oral hepatitis C virus therapy to reduce recurrent viremia and increase SVRAlimohammadi, A. / Raycraft, T. / Shahi, R. / Singh, A. / Kiani, G. / Conway, B. et al. | 2017
- S294
-
Feasibility and acceptability of a group medical visit intervention to improve hepatitis C virus treatment uptake among persons who inject drugs (PWID) in a primary care settingNorton, B. / McMurry, C. / Gover, M. / Cunningham, C. / Litwin, A. et al. | 2017
- S295
-
Outcome of patients with compensated liver cirrhosis with hepatitis B virus + hepatitis C virus coinfection treated with paritaprevir/ombitasvir/ritonavir, dasabuvir with ribavirin: a national cohort studyPreda, C. / Popescu, C. / Constantinescu, I. / Manuc, M. / Tugui, L. / Voiosu, R. / Ceausu, E. / Diculescu, M. / Oproiu, A. et al. | 2017
- S296
-
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and meta-analysisChen, G.F. / Wang, C. / Chen, J. / Ji, D. / Shao, Q. / Li, F. / Li, B. / Wu, V. / Wong, A. / Wang, Y.D. et al. | 2017
- S297
-
Clinically meaningful differences in health-related quality of life and fatigue in patients with hepatitis C virus infection treated with elbasvir/grazoprevir compared to sofosbuvir with pegylated interferon and ribavirinNwankwo, C. / King-Kallimanis, B. / Corman, S. / Qiu, J. / Patel, S. / Arduino, J.M. / Platt, H.L. / Sperl, J. et al. | 2017
- S298
-
Projected long term impact of elbasvir/grazoprevir compared to sofosbuvir plus pegylated interferon/ribavirin in chronic hepatitis C virus genotype 1 and 4 patients in Italy: translation of the C-EDGE Head-2-Head study findingsNwankwo, C. / Batterson, R. / Todd, E. / Jiang, Y. / Platt, H.L. / Meng, Y. et al. | 2017
- S299
-
Efficacy and safety of sofosbuvir and daclatasvir for 8 weeks in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus Genotype 3 InfectionHezode, C. / Leroy, V. / Rosa, I. / Roudot-Thoraval, F. / Pawlotsky, J.-M. / de Ledinghen, V. / Bronowicki, J.-P. et al. | 2017
- S300
-
ZIRCON: pharmacokinetics, safety, and efficacy of ombitasvir/ paritaprevir/ritonavir ± dasabuvir ± ribavirin in adolescents with genotype 1 or 4 hepatitis C virus infectionLeung, D.H. / Yao, B. / Viani, R.M. / Gonzalez-Peralta, R.P. / Jonas, M.M. / Lobritto, S.J. / Narkewicz, M.R. / Sokal, E. / Fortuny, C. / Hsu, E. et al. | 2017
- S301
-
Effects of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection on serotonin metabolism, depression scores and fatigueHahn, D. / Stokes, C.S. / Kaiser, R. / Meyer, M.R. / Lammert, F. / Grünhage, F. et al. | 2017
- S301
-
Real world efficacy of 12 weeks sofosbuvir, daclastivir with ribavirin among cirrhotic pre and post-transplant genotype 3 hepatitis C infected patientsSchmidt-Martin, D. / Bufton, S. / Roberts, M. / Rye, K. / Singhal, S. / Eldred, S. / Perry, I. / Corbett, C. / Unitt, E. / Wood, V. et al. | 2017
- S302
-
Treatment outcomes of hepatitis C virus recombinant form 2k/1b with sofosbuvir based regimens in GeorgiaZakalashvili, M. / Zarkua, J. / Weizenegger, M. / Bartel, J. / Raabe, M. / Telia, T. / Zhamutashvili, M. / Metreveli, S. / Barnova, M. / Abramishvili, N. et al. | 2017
- S305
-
Prospective study of autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct acting antiviralsFernández, D.A. / Suñer, M.A. / Iglesias, M.J.F. / Nuñez, C.L. / Matamala, I.S. / Molés, X.Q. / Mante, X.A. et al. | 2017
- S306
-
High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2)Serfaty, L. / Pianko, S. / Ari, Z.B. / Laursen, A.L. / Hansen, J. / Gane, E.J. / Huang, H.-C. / Jin, S. / Bourque, J. / Liu, H. et al. | 2017
- S307
-
Real-world utilization of the new fixed-dose combination elbasvir/grazoprevir in adult patients with chronic hepatitis C in Canada: Z-PROFILE studyTam, E. / Fraser, C. / Tremblay, J. / Conway, B. / Trottier, B. / Ramji, A. / Borgia, S. / Stewart, K. / Trépanier, J. / Chalabi, Y. et al. | 2017
- S308
-
High efficacy of 8 weeks of ledipasvir/sofosbuvir in real-world treatmentTang, L. / Parker, A. / Flores, Y. / Dellario, M. / Dickson, C. / Amoroso, A. / Kottilil, S. / Wilson, E. et al. | 2017
- S309
-
Improvement of glycemic state among responders to sofosbuvir – based DAAsAlem, S.A. / Fouad, R. / Elsharkawy, A. / Adel, E. / Abdellatif, Z. / Musa, S. / Nagy, A. / Hussein, M.S. / Yosry, A. / Esmat, G. et al. | 2017
- S310
-
Treatment with SOF/VEL or SOF/VEL/VOX is well tolerated and results in high SVR12 in genotype 1–6 HCV infected patients with minimal fibrosis: a retrospective analysis of the ASTRAL and POLARIS clinical studiesLawitz, E. / Bourlière, M. / Han, L. / Mcnally, J. / Stamm, L.M. / Brainard, D.M. / Subramanian, G.M. / Flamm, S.L. / Reddy, K.R. et al. | 2017
- S311
-
Evolution of platelets in chronic hepatitis C infected patients and advanced liver fibrosis after direct-acting antiviral treatmentSáez-Royuela, F. / Linares, P. / Calvo, S. / Martín, I. / Almohalla, C. / Jorquera, F. / Ramos, H. / De Benito, M. / Bernad, B. / Alvarez, B. et al. | 2017
- S314
-
Successful management of drug interactions with ritonavir-containing hepatitis C virus regimens in routine clinical practiceMarra, F. / Boyle, A. / Fox, R. / Fleming, C. / Reilly, E. / Heydtmann, M. / Datta, S. / Priest, M. / Barclay, S.T. et al. | 2017
- S315
-
Efficacy and safety of the fixed-dose combination regimen of MK3 [MK-3682/grazoprevir/ruzasvir] with or without ribavirin in non-cirrhotic or cirrhotic patients with chronic HCV GT1, 2, 3, 4 or 6 infection (Parts A & B of C-CREST-1 & 2)Lawitz, E. / Yoshida, E.M. / Buti, M. / Vierling, J.M. / Almasio, P.L. / Bruno, S. / Ruane, P.J. / Hassanein, T.I. / Mullhaupt, B. / Pearlman, B. et al. | 2017
- S316
-
Chronic hepatitis C in children in the Russian Federation: a multicenter studyVolynets, G.V. / Skvortsova, T.A. / Potapov, A.S. / Panfilova, V.N. / Rogozina, N.V. / Nikitin, A.V. / Giaquinto, C. / Thorne, C. / Turkova, A. et al. | 2017
- S318
-
DC-SIGN polymorphisms associate with sexual hepatitis C virus transmission and DC-SIGN m-RNA expression levelsSteba, G.S. / Koekkoek, S.M. / Vanhommerig, J.W. / Brinkman, K. / van der Meer, J.T.M. / Prins, M. / Paxton, W.A. / Molenkamp, R. / Schinkel, J. et al. | 2017
- S319
-
Allelic variantes of Aurora B kinase gene can be related with fibrosis progression in chronic hepatitis CFrancisco-Recuero, I. / Gil, A.I. / Madejón, A. / Sánchez-Pacheco, A. / Romero, M. / García, A. / Olveira, A. / Castillo, P. / Erdonzaín, J.C. / Perales, C. et al. | 2017
- S320
-
Hepatocyte single cell sequencing to identify transcript modulation by hepatitis C virusDebes, J.D. / Reilly, C. / van Oord, G. / Bohjanen, P.R. / vanwolleghem, T. / Boonstra, A. et al. | 2017
- S321
-
Identification of glycogen synthase kinase 3 beta as a novel host factor of hepatitis C virus replicationSaleh, M. / Rüschenbaum, S. / Welsch, C. / Zeuzem, S. / Moradpour, D. / Gouttenoire, J. / Lange, C.M. et al. | 2017
- S322
-
MIV-802, a uridine nucleotide prodrug, is a more potent inhibitor of hepatitis C virus genotype 3 replication than sofosbuvirLana, E. / Brenndörfer, E. / Kylefjord, H. / Eneroth, A. / Pinho, P. / Rosenquist, Å. / Targett-Adams, P. / Bethell, R. et al. | 2017
- S323
-
Hepatitis C virus-induced MiR-21 activation triggers steatosis and promotes hepatitis C virus life cycleClément, S. / Sobolewski, C. / Rojas, A. / Bonifacio, G. / Goossens, N. / Conzelmann, S. / Gomes, D. / Calo, N. / Negro, F. / Foti, M. et al. | 2017
- S324
-
Exosomal miRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis C virus infectionQi, Z. / Qian, X. / Xu, C. / Fang, S. / Zhao, P. / Wang, Y. / Liu, H. / Yuan, W. et al. | 2017
- S326
-
MAIT cell frequency and function in blood and liver of hepatitis C virus mono- and hepatitis C virus/human immunodeficiency virus co-infected patients with mild versus advanced fibrosisBeudeker, B. / van Oord, G. / Arends, J. / zur Wiesch, J.S. / de Knegt, R. / Verbon, A. / Boonstra, A. / Claassen, M. et al. | 2017
- S327
-
Hepatitis B virus affects dendritic cell activation and their crosstalk with natural killer cellsDe Pasquale, C. / Campana, S. / Barberi, C. / Raimondo, G. / Pollicino, T. / Ferlazzo, G. et al. | 2017
- S328
-
N22 region based dot blot assay: an alternative to PCR for detection of Torque teno virus infectionMankotia, D.S. / Joshi, Y.K. / Irshad, M. et al. | 2017
- S330
-
Targeting NF-KappaB dependent intrinsic innate immune pathways activated by DNA and hepatitis B virus to facilitate in vitro hepatitis b virus infectionYoneda, M. / Hyun, J. / Schiff, E. / Thomas, E. et al. | 2017
- S333
-
A protective role of IL-22BP in acute liver injuryKleinschmidt, D. / Giannou, A.D. / Kempski, J. / Steglich, B. / Huber, F.J. / Shiri, A.M. / Tiegs, G. / Gagliani, N. / Huber, S. et al. | 2017
- S334
-
Combining renewable human liver tissue and novel extracorporeal devices to deliver mammalian liver supportRashidi, H. / Dunphy, S. / Ginai, M. / Dong, H. / Alwahsh, S. / Luu, N.T. / Newsome, P. / Forbes, S. / Bradley, M. / Callanan, A. et al. | 2017
- S335
-
The Role of chemokine (C-C motif) ligand 2 and the diet influence in the energy metabolismLuciano, F. / Cabré, N. / Hernandez-Aguilera, A. / Baiges-Gaya, G. / Garcia-Heredia, A. / Fernández-Arroyo, S. / Camps, J. / Joven, J. et al. | 2017
- S336
-
IL-33 protects Murine viral fulminant hepatitis by targeting coagulation hallmark protein Fgl2/Fibroleukin expressionYu, H. / Liu, Y. / Wang, H. / Yan, W. / Huang, J. / Luo, X. / Ning, Q. et al. | 2017
- S337
-
Formation of bile canaliculi in liver progenitor cell-derived hepatocytes determines clinical outcome of acute-on-chronic liver failureYuan, X. / Gu, W. / Wandrer, F. / Dewidar, B. / Munker, S. / Hähnel, B. / Liebe, R. / Ebert, M.P. / Qiang, X. / Bantel, H. et al. | 2017
- S338
-
The hepatoprotective cytokine Cardiotrophin-1 (CT-1) attenuates inflammation and prevents the systemic effects of endotoxemia by promoting M2 macrophage polarizationVélez-Qrtiz, J.M. / María, E.S. / Larequi, E. / Colodrero, P. / Reboredo, M. / Muntané, J. / Padillo, F.J. / Prieto, J. / Hervás-Stubb, S. / Bustos, M. et al. | 2017
- S340
-
Long term mortality is increased in patients surviving acute liver failure without liver transplantationDonnelly, M.C. / Williams, L. / Murray, B. / Taylor, C. / Springbett, A. / Davidson, J. / Baird, A. / Martin, K. / Moore, J.K. / Lone, N. et al. | 2017
- S341
-
Melatonin protects liver in experimental severe acute liver failureMarroni, N.A.P. / Salvi, J.D.O. / Schemitt, E.G. / Colares, J.R. / Hartmann, R.M. / Licks, F. / Santos, V.F.L.D. / Marroni, C.A. et al. | 2017
- S342
-
Multi-state modelling of progression from acute liver failure to intracranial hypertension and deathBjerring, P.N. / Larsen, F.S. et al. | 2017
- S343
-
External validation of the USALFSG acute liver failure outcome prediction criteriaBernal, W. / Donnelly, M.C. / Durkalski-Mauldin, V.L. / Simpson, K. / Wang, Y. / Wendon, J. et al. | 2017
- S344
-
Main drivers of outcome differ between short and long-term in severe alcoholic hepatitis: a prospective studyLouvet, A. / Labreuche, J. / Artru, F. / Bouthors, A. / Rolland, B. / Saffers, P. / Dharancy, S. / Lassailly, G. / Canva-Delcambre, V. / Duhamel, A. et al. | 2017
- S345
-
Variation in the use of corticosteroids for the treatment of acute severe alcoholic hepatitis in the post-STOPAH era: results of a UK national surveyDhanda, A. / Atkinson, S. / Thursz, M. et al. | 2017
- S347
-
Effect of alcohol on the IL-6 mediated inflammatory response in a new mouse model of acute-on-chronic liver injuryKaratayli, E. / Hall, R.A. / Dooley, S. / Lammert, F. et al. | 2017
- S348
-
Differential gender-related impact of PNPLA3 and CD14 polymorphism on the risk of developing alcoholic cirrhosisMischitelli, M. / Mancina, R. / Ferri, F. / Farcomeni, A. / Molinaro, A. / Maffongelli, A. / Poli, E. / Rotondo, C. / Codazzo, C. / Galli, D. et al. | 2017
- S349
-
Carcinogenic Etheno DNA -adducts in alcohol liver disease: correlation with cytochrome P-4502E1 and fibrosisSeitz, H.K. / Pecerella, T. / Flechtenmacher, C. / Straub, B.K. / Stickel, F. / Bruckner, T. / Bartsch, H. / Mueller, S. / Peccerella, T. et al. | 2017
- S350
-
Effects of probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) in the treatment of mild alcoholic hepatitis: randomized controlled multicenter studySuk, K.T. / Kim, D.J. / Yang, Y.J. / Hong, M. / Kim, S.E. / Park, J.W. / Kim, H.S. / Jang, M.K. / Park, C.K. et al. | 2017
- S352
-
The role of ethnicity in autoimmune hepatitisGerussi, A. / Halliday, N. / Roccarina, D. / Saffioti, F. / Polly, P. / Marshall, A. / Thorburn, D. et al. | 2017
- S353
-
Evaluation of 6-thioguanine therapy in autoimmune hepatitisvan den Brand, F.F. / de Boer, Y.S. / Verwer, B.J. / Bloemena, E. / de Boer, N. / Mulder, C.J. / van Nieuwkerk, C.M. / Bouma, G. et al. | 2017
- S354
-
Dysbiosis of the gut microbiota and increased gut permeability characterize secondary sclerosing cholangitis in critically ill patients (SSC-CIP)Blesl, A. / Horvath, A. / Jüngst, C. / Leber, B. / Schmerboeck, B. / Tawdrous, M. / Stiegler, P. / Rainer, F. / Spindelboeck, W. / Fickert, P. et al. | 2017
- S355
-
The novel hexokinase 1 antibodies are useful for the diagnosis and associated with bad prognosis in primary biliary cholangitisReig, A. / Garcia, M. / Shums, Z. / Milo, J. / Encabo, S. / Bentow, C. / Mahler, M. / Romera, M.A. / Viñas, O. / Norman, G.L. et al. | 2017
- S356
-
Prompt initiation of intravenous corticosteroids prevents deterioration of acute/severe autoimmune hepatitis (AS-AIH) and the need for liver transplantation (LT)Zachou, K. / Arvaniti, P. / Gatselis, N.K. / Azariadi, K. / Koukoulis, G.K. / Dalekos, G.N. et al. | 2017
- S360
-
Prospective validation of serum alkaline phosphatase for the prediction of disease progression in a randomized trial of patients with primary sclerosing cholangitisLevy, C. / Eksteen, B. / Shiffman, M. / Janssen, H. / Montano-Loza, A. / Ding, D. / Jia, C. / Mccolgan, B. / Myers, R. / Subramanian, M. et al. | 2017
- S361
-
Autoimmune Hepatitis with normal IgG levels at diagnosis: subtype with a higher rate of successful treatment withdrawal?Hartl, J. / Asghar, A. / Wong, G.W. / Pape, S. / Lohse, A.W. / Drenth, J.P. / Oo, Y.H. / Michael, H.A. / Schramm, C. et al. | 2017
- S363
-
Macrophage migration inhibitory factor (MIF) modulates T-cell proliferation and hepatic inflammation in a model of autoimmune liver diseaseRoberts, S. / Leng, L. / Soroka, C.J. / Boyer, J.L. / Bucala, R. / Assis, D.N. et al. | 2017
- S364
-
Obeticholic acid therapy improves cognitive decline in cholestatic liver diseaseMillar, B. / Richardson, C. / McKay, K. / Pechlivanis, A. / Innes, B. / Kirby, J. / Jones, D. / Holmes, E. / Oakley, F. et al. | 2017
- S365
-
Magnetic resonance imaging findings are related with serum and endoscopic markers of disease activity and severity in primary sclerosing cholangitisTenca, A. / Lind, K. / Lantto, E. / Mustonen, H. / Kolho, K.-L. / Boyd, S. / Arola, J. / Farkkila, M. et al. | 2017
- S366
-
Sortilin regulates ductular reaction and bile duct morphogenesis in cholestasis-induced liver injury via IL-6 and LIFZvibel, I. / Hubel, E. / Avraham, R. / Shibolet, O. et al. | 2017
- S367
-
Exhaustive blood immune phenotype of patients with autoimmune hepatitisRenand, A.P. / Judor, J.-P. / Aublé, H. / Archambeaud, I. / Mosnier, J.-F. / Gournay, J. / Brouard, S. / Conchon, S. et al. | 2017
- S368
-
Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosisRainer, F. / Horvath, A. / Sandahl, T.D. / Leber, B. / Schmerboeck, B. / Blesl, A. / Krones, E. / Baumann-Durchschein, F. / Douschan, P. / Spindelboeck, W. et al. | 2017
- S369
-
3 times higher healthcare cost in chronic hepatitis B patients compared to non-chronic hepatitis B controls especially those with decompensated liver disease: United States real world healthcare utilization and cost analysisNguyen, M.H. / Lim, J. / Ozbay, A.B. / Shreay, S. / Liou, I. / Meyer, N. / Dusheiko, G. / Gordon, S. et al. | 2017
- S370
-
Abnormal MOCA scores are common and predict morbidity and mortality in patients with cirrhosisNey, M. / Bhardwaj, P. / Dobbs, B. / Ma, M. / Bailey, R.J. / Abraldes, J. / Rolfson, D. / Tandon, P. et al. | 2017
- S371
-
Hepatic encephalopathy in cirrhotic patients with bacterial infections: prevalence, clinical characteristics and correlation with prognosis: a prospective studyPiedade, J. / Guimarães, L. / Rocha, T. / Victor, L. / Baldin, C. / Rodrigues, B. / Veiga, Z. / Agoglia, L. / Fernandes, F. / Pereira, G.H.S. et al. | 2017
- S372
-
Palliative care access for hospitalized patients with end stage liver disease across the United StatesRush, B. / Walley, K. / Celi, L.A. / Rajoriya, N. / Brahmania, M. et al. | 2017
- S373
-
Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severityMandorfer, M. / Schwabl, P. / Bucsics, T. / Paternostro, R. / Pomej, K. / Ay, J. Thaler C. / Quehenberger, P. / Trauner, M. / Peck-Radosavljevic, M. / Reiberger, T. et al. | 2017
- S374
-
Comparison of efficacy of cefotaxime, ceftriaxone, and ciprofloxacin for the treatment of spontaneous bacterial peritonitis in patients with liver cirrhosis: a randomized controlled trialYim, H.J. / Suh, S.J. / Jung, Y.K. / Kim, M.Y. / Baik, S.K. / Kim, H.S. / Kim, Y.S. / Park, S.Y. / Kim, B.I. / Park, J.Y. et al. | 2017
- S375
-
A multimodality assessment of liver fibrosis in asymptomatic Fontan patientsMunsterman, I. / Duijnhouwer, T. / Bronckhorst, C. / Drenth, J. / van Dijk, A. / Tjwa, E. et al. | 2017
- S377
-
An Innovative app focused on patients and caregivers significantly decreases avoidable and HE-related readmissions in cirrhotic patientsGanapathy, D. / Lachar, J. / Acharya, C. / White, M. / Sterling, R.K. / Matherly, S. / Puri, P. / Stravitz, R.T. / Siddiqui, M.S. / Sanyal, A.J. et al. | 2017
- S378
-
Oral glutamine challenge predicts risk and defines hepatic encephalopathy typesAmpuero, J. / Gómez, A.G. / Del Mar Viloria, M. / Camacho, I. / Moro, A. / Romero-Gomez, M. et al. | 2017
- S379
-
The Quick SOFA, a simple bedside score, identifies hospitalized cirrhotic patients with poor outcomesCervoni, J.-P. / Weil, D. / Bureau, C. / Oberti, F. / Anty, R. / Louvet, A. / Plessier, A. / Rudler, M. / Heurgué-Berlot, A. / Rosa, I. et al. | 2017
- S380
-
Performance of upper gastrointestinal bleeding risk assessment scores in variceal bleeding: a prospective international multicenter studyNgu, J.H. / Laursen, S.B. / Chin, Y.K. / Laine, L. / Dalton, H.R. / Murray, I.A. / Schultz, M. / Nadkarni, N.V. / Stanley, A.J. et al. | 2017
- S381
-
Acute hemodynamic response to beta-blockers: factors influencing its outcomeFortea, J.I. / Puente, A. / Ruiz, P. / Arias-Loste, M.T. / Alvarez, S. / Cabezas, J. / Cuadrado, A. / Llerena, S. / Estébanez, A. / Casafont, F. et al. | 2017
- S382
-
Medication beliefs predict low medication adherence in people with decompensated cirrhosisHayward, K.L. / Valery, P.C. / Martin, J.H. / Karmakar, A. / Patel, P.J. / Horsfall, L.U. / Irvine, K.M. / Stuart, K.A. / Tallis, C.J. / Wright, P.L. et al. | 2017
- S383
-
Presence of ACLF is the best predictor of mortality in patients with decompensated chronic liver disease managed in a non-specialist environmentBurke, L. / Lane, C. / Gao-Du, Y. / Driver, R. / Corless, L. et al. | 2017
- S384
-
Rifaximin-α is associated with reductions in emergency department resource use in UK patients with hepatic encephalopathy: real world evidence from the IMPRESS studyHudson, M. / Di Maggio, P. / Cipelli, R. / Aspinall, R. et al. | 2017
- S385
-
Cellulitis is a common precipitant of acute kidney injury and mortality in patients with cirrhosisde Paredes, A.G.G. / Téllez, L. / Rodríguez-Gandía, M.Á. / Martínez, J. / Gea, F. / Albillos, A. et al. | 2017
- S387
-
Effect of terlipressin treatment in liver transplant-eligible patients with hepatorenal syndromeNguyen-Tat, M. / Häring, M.-T. / Zimmermann, T. / Nagel, M. / Weinmann-Menke, J. / Rey, J.W. / Wörns, M.A. / Galle, P.R. / Marquardt, J.U. et al. | 2017
- S388
-
Abnormalities in skin temperature and its 24-hour rhythm in patients with cirrhosis: sleep-wake and general clinical implicationsGarrido, M. / Saccardo, D. / De Rui, M. / Vettore, E. / Verardo, A. / Carraro, P. / Di Vitofrancesco, N. / Mani, A.R. / Angeli, P. / Bolognesi, M. et al. | 2017
- S389
-
Glutamine synthetase in endothelial cells of the blood-brain barrier: less but not insignificant?Oliveira, M.M. / Tremblay, M. / Rose, C.F. et al. | 2017
- S390
-
Survival predictors in cirrhotic patients with refractory ascites treated with transjugular intrahepatic portosystemic shuntAicart-Ramos, M. / Ibáñez-Samaniego, L. / Martínez-Lozano, H. / Catalina, M.-V. / Rodríguez-de Santiago, E. / Bañares, R. / Albillos, A. et al. | 2017
- S391
-
Cannabinoid receptor 1 mediates M1 polarization of bone marrow-derived monocytes/macrophages via RhoA/NF-κB p65 and ERK1/2 signaling pathways respectively in mouse fibrotic liverTian, L. / Yang, L. / Li, W. / Fan, X. / Yang, J. / Chang, N. / Xie, J. / Li, L. et al. | 2017
- S392
-
Systemic delivery of gene therapy – a proof of concept study in a model of cirrhosis and portal hypertensionJones, H. / Habtesion, A. / Mehta, G. / Jalan, R. / Davies, N.A. / Mookerjee, R.P. et al. | 2017
- S393
-
Inhibition of macrophage infiltrations by thalidomide improves muscle wasting of cirrhotic ratsLin, H.-C. / Li, T.-H. / Lee, P.-C. / Liu, W.-C. / Huang, S.-F. / Lee, K.-C. / Hou, M.-C. / Yang, Y.-Y. et al. | 2017
- S394
-
Vascular morphology alterations during liver cirrhogenesis in ratsPeeters, G. / Debbaut, C. / De Vos, W.H. / Cornillie, P. / De Schryver, T. / Monbaliu, D. / Laleman, W. / Segers, P. et al. | 2017
- S395
-
Alpha Toocotrienol causes apoptosis of activated Hepatic Stelate cells through lysosome mitochondrial axis in INH induced liver fibrosis: an in-vitro studySantra, S. / Chowdhury, A. / Bishnu, D. / Dhali, G.K. / Santra, A. et al. | 2017
- S396
-
The novel macrophage activation marker soluble Mannose Receptor, and soluble CD163, are elevated after acetaminophen intoxication in relation to liver disease severitySiggaard, C.B. / Kazankov, K. / Møller, H.J. / Donnelly, M.C. / Simpson, K.J. / Grønbæk, H. et al. | 2017
- S397
-
p62/sqstm1 in a drug-induced model of hepatotoxicity: a novel role beyond autophagyAlegre, F. / Polo, M. / Marti-Rodrigo, A. / Moragrega, A.B. / Esplugues, J.V. / Blas-Garcia, A. / Apostolova, N. et al. | 2017
- S398
-
Free cholesterol accumulation in liver sinusoidal endothelial cells exacerbates acetaminophen hepatotoxicity in miceTeratani, T. / Tomita, K. / Suzuki, T. / Furuhashi, H. / Irie, R. / Hida, S. / Okada, Y. / Kurihara, C. / Ebinuma, H. / Nakamoto, N. et al. | 2017
- S399
-
Prevalence and severity of liver injury after pulsed methylprednisolone therapy in multiple sclerosis patientsBiolato, M. / Nociti, V. / Marrone, G. / Liguori, A. / De Fino, C. / Bianco, A. / Mirabella, M. / Grieco, A. et al. | 2017
- S401
-
Influence of host characteristics and pharmacological properties on type of liver injury in hepatotoxicityGonzalez-Jimenez, A. / Chen, M. / McEuen, K. / Stephens, C. / Medina-Caliz, I. / Robles-diaz, M. / Slim, M. / Lucena, M.I. / Suzuki, A. / Andrade, R. et al. | 2017
- S403
-
Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infectionPallarés, C. / Carvalho-Gomes, A.S. / Conde, I. / Di Maira, T. / Hontangas, V. / Aguilera, V. / López-Labrador, F.X. / Berenguer, M. et al. | 2017
- S404
-
Screening for HCV in pregnant women and their partnersMillbourn, C. / Lybeck, C. / Fadl, H. / Fredlund, H. / Lindahl, K. / Duberg, A.-S. et al. | 2017
- S405
-
HCV elimination among people who inject drugs. What would happen after the WHO HCV elimination target is achieved?Gountas, I. / Gamkrelidze, I. / Pasini, K. / Blach, S. / Razavi-Shearer, D. / Estes, C. / Razavi, H. et al. | 2017
- S406
-
Treatment and primary prevention in people who inject drugs (PWID) for chronic Hepatitis C (CHC): is elimination possible in a high prevalence setting?Gountas, I. / Sypsa, V. / Anagnostou, O. / Martin, N. / Vickerman, P. / Kafetzopoulos, E. / Hatzakis, A. et al. | 2017
- S408
-
Do elevated liver values necessarily indicate a health problem or could poorly defined upper limits of normal be an issue? Alanine aminotransferase and gamma-glutamyltransferase depend strongly on ageWiegand, J. / Petroff, D. / Bätz, O. / Jedrysiak, K. / Kramer, J. / Wolffram, I. / Berg, T. et al. | 2017
- S409
-
Smoking and metabolic syndrome components are independent predictors of mortality in patients with chronic liver disease in the United StatesWijarnpreecha, K. / Scribani, M. / Ungprasert, P. / Merrell, N. / Raymond, P. et al. | 2017
- S410
-
Chronic hepatitis C diagnosis increases sick leave and disability pensionBuesch, K. / Hansson, F. / Holton, M. / Lagging, M. / Westin, J. / Kövamees, J. / Sällberg, M. / Söderholm, J. et al. | 2017
- S412
-
Hepatitis prevention, control, and elimination program in Mongolia: national hepatitis elimination program in a country with the highest burden of viral hepatitis in the worldDashdorj, N. / Bungert, A.S. / Genden, Z. / Dendev, B. / Duger, D. / Dagvadorj, A. / Yagaanbuyant, D. et al. | 2017
- S413
-
Implementing the WHO Global Health Sector Strategy on Viral Hepatitis in Denmark – modeling the effects of community-based care on the elimination of HCV by 2030Henriksen, O. / Christensen, P.B. / Lazarus, J.V. / Awad, T. / Øvrehus, A.L.H. et al. | 2017
- S414
-
Effectiveness and cost-effectiveness of antiviral treatment initiation in hepatitis C related decompensated cirrhosis in FranceWillmington, C. / Ganne-Carrié, N. / Roudot-Thoraval, F. / Leroy, V. / Fontaine, H. / Canva-Delcambre, V. / Larrey, D. / Pol, S. / Mathurin, P. / Yazdanpanah, Y. et al. | 2017
- S415
-
Prevalence of end of life criteria in patients with liver disease in South West EnglandThalheimer, U. / Giannelli, V. et al. | 2017
- S416
-
Long-term disease progression in chronic hepatitis B Chinese patients with comorbid nonalcoholic fatty liver diseaseFan, J.G. / Chen, G.F. / Ji, D. / Ye, D.W. / Wang, C. / Shao, Q. / Li, F. / Li, B. / Wu, V. / Wong, A. et al. | 2017
- S417
-
Steatohepatitis: differential features on quantitative liver-spleen scanHoefs, J.C. et al. | 2017
- S418
-
Hepatic steatosis in an adult population: stronger correlation with the presence of obesity and insulin resistance than with the dietary pattern. Results from a cross-sectional studyLeitão, J. / Cochicho, J. / Carvalhana, S. / Velasco, F. / Silva, A. / Medeiros, I. / Alves, A.C. / Bourbon, M. / Oliveiros, B. / Rodrigues, V. et al. | 2017
- S419
-
The COMMANDS study: improving community-based diagnosis and management of non-alcoholic fatty liver diseaseBurke, L. / Williams, B. / Mann, V. / Wong, L.L. / Corless, L. / Abouda, G. et al. | 2017
- S420
-
Presarcopenia is associated with non-alcoholic fatty liver disease (NAFLD) in older women: the Rotterdam StudyAlferink, L.J.M. / Trajanoska, K. / Schoufour, J.D. / Taimr, P. / Ikram, A.M. / Janssen, H.L.A. / Metselaar, H.J. / Rivadeneira, F. / Murad, S.D. et al. | 2017
- S421
-
NAFLD as an indication for liver transplantation in the Nordic countries – a cohort study during 1982-2015Holmer, M. / Melum, E. / Isoniemi, H. / Ericzon, B.-G. / Castedal, M. / Nordin, A. / Schultz, N.A. / Rasmussen, A. / Line, P.-D. / Stål, P. et al. | 2017
- S422
-
Exploring the patient perceived impact of non-alcoholic steatohepatitisDoward, L.C. / Balp, M.-M. / Stewart, K.E. / Cryer, D. / Langford, A. / Twiss, J. / Agashivala, N. / Brass, C.A. / Anstee, Q.M. / Sanyal, A. et al. | 2017
- S423
-
Nonalcoholic fatty liver with hepatic arterial buffer response strongly caused metabolic diseases, while bright pancreas was not associated with metabolic diseases – 5 years’ cohortHirooka, M. / Koizumi, Y. / Miyake, T. / Yukimoto, A. / Nakamura, Y. / Imai, Y. / Watanabe, T. / Yoshida, O. / Tokumoto, Y. / Abe, M. et al. | 2017
- S424
-
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patientsLemoine, M. / Lacombe, K. / Bastard, J.-P. / Fonquernie, L. / Sébire, M. / Fellahi, S. / Valin, N. / Capeau, J. / Girard, P.-M. / Meynard, J.-L. et al. | 2017
- S425
-
SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidityStrasser, M. / Feldman, A. / Schranz, M. / Stechemesser, L. / Denkmayr, L. / Ruhaltinger, S. / Strebinger, G. / Huber-Schönauer, U. / Niederseer, D. / Zandanell, S. et al. | 2017
- S426
-
Effect of a probiotic on fatty liver index and liver stiffness in NAFLD patients: randomized clinical trialKobyliak, N. / Bosak, N. / Falalyeyeva, T. / Beregova, T. / Bodnar, P. et al. | 2017
- S428
-
Natural history of patients with NASH followed at a tertiary referral liver center: impact of presenting features.Mantry, P.S. / Mehta, A.P. / Kumar, A. / Weinstein, J.S. / Nazario, H. / Pagadala, M. / Barnes, M. / Habib, A. et al. | 2017
- S429
-
Hepatocyte nuclear factor 4α played a different role in lipotoxicity and bile acid toxicity in non-alcoholic fatty liver disease modelLee, J.S. / Jun, D.W. / Ahn, S.B. / Saeed, W.K. / Chae, Y.J. / Jeong, J.Y. / Kang, H.T. / Sohn, J.H. / Jang, E.C. / Kang, B.-K. et al. | 2017
- S431
-
Obeticholic acid improves histological, biochemical and gene expression profiles in Gubra AMLN mice with biopsy-confirmed NASHRoth, J. / Feigh, M. / Veidal, S. / Rigbolt, K. / Young, M. et al. | 2017
- S432
-
New GLP-1 agonist dulaglutide improves metabolic dysfunction and extenuates development of non-acoholic steatohepatitis in miceHupa, K.L. / Hardtke-Wolenski, M. / Manns, M.P. / Jaeckel, E. et al. | 2017
- S433
-
Increased non-shivering thermogenesis had preventive but no therapeutic effects on non-alcoholic steatohepatitisPoekes, L. / Horsmans, Y. / Farrell, G. / Leclercq, I.A. et al. | 2017
- S435
-
Novel PCR-based method to detect fungal colonization of ascites, bile and duodenal fluid in patients with acute on chronic liver failure (ACLF) or after orthotope liver transplantation (OLT)Herber, A. / Engelmann, C. / Krohn, S. / Zeller, K. / Müller, N.F. / Petros, S. / Bercker, S. / Laudi, S. / Hoffmeister, A. / Berg, T. et al. | 2017
- S436
-
Model for end stage liver disease score dynamics in patients awaiting liver transplantation and waitlist outcomesMannalithara, A. / Chan, J.L. / Hagerty, D. / Kim, W.R. et al. | 2017
- S437
-
The impact of multidisciplinary support to alcohol misusers at risk of alcohol relapse after liver transplantationLattanzi, B. / Ledda, R. / Di Gregorio, V. / Galli, A.M. / Mennini, G. / D’Ambrosio, D. / Rossi, M. / Corradini, S.G. / Attilia, M.L. / Merli, M. et al. | 2017
- S439
-
Preoperative intra-platelet serotonin levels are associated with early disease recurrence after liver resection in humansPereyra, D. / Padickakudy, R. / Haegele, S. / Offensperger, F. / Oehlberger, L. / Schwarz, C. / Assinger, A. / Brostjan, C. / Gruenberger, T. / Starlinger, P. et al. | 2017
- S440
-
Leaky gut does not affect the risk of infectious complications and survival in liver transplant recipients: comparison with cirrhotic patients and healthy individualsPonziani, F.R. / Valenza, V. / Lorusso, M. / Carvelli, M.E. / Paone, R. / Siciliano, M. / Avolio, A.W. / Grieco, A. / Agnes, S. / Gasbarrini, A. et al. | 2017
- S442
-
Laparoscopic liver resection for hepatocellular carcinoma located in segments 7 or 8Guro, H. / Cho, J.Y. / Jang, J.S. / Choi, Y. / Kim, H. / Kim, S. / Kwon, S.U. et al. | 2017
- S443
-
Impact of sustained virological response to interferon therapy for chronic hepatitis C on recurrence and long-term survival in patients with hepatocellular carcinomaShinkawa, H. / Hasegawa, K. / Arita, J. / Akamatsu, N. / Kaneko, J. / Sakamoto, Y. / Kokudo, N. et al. | 2017
- S444
-
Risk of hepatocellular carcinoma recurrence is changing according to serial liver stiffness measurement follow-up in patients who underwent radiofrequency ablation for hepatocellular carcinomaKim, H. / Kwon, S. / Lee, J. / Yoon, J. / Lee, Y. / Kweon, Y. / Tak, W. / Park, S. / Jang, S. / Hur, K. et al. | 2017
- S445
-
Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) – HEPAVACMayer, A. / Accolla, R. / Ma, Y.T. / Heidenreich, R. / Koenigsrainer, A. / Izzo, F. / Loeffler, M. / Flohr, C. / Mueller, P. / Kutscher, S. et al. | 2017
- S446
-
Conditional probability of long-term survival in patients with locally advanced and metastatic hilar cholangiocarcinomaGaspersz, M. / Buettner, S. / van Vugt, J. / Roos, E. / Coelen, R. / van Gulik, T. / IJzermans, J. / Koerkamp, B.G. et al. | 2017
- S447
-
Black hepatocellular carcinoma patients diagnosed after 2010 have worse long-term survival than white patientsEstevez, J. / Yang, J.D. / Leong, J. / Nguyen, P. / Giama, N. / Roberts, L. / Schwartz, M. / Nguyen, M. et al. | 2017
- S448
-
Functional health literacy can affect patient perception for the need for liver imaging for HCC screeningShaw, J. / Patidar, K. / Dharel, N. / Driscoll, C. / Heuman, D. / Bajaj, J.S. et al. | 2017
- S449
-
The risk of hepatitis B virus reactivation is considerably high during sorafenib therapy in patients with advanced hepatocellular carcinomaSuh, S.J. / Yim, H.J. / Seo, J.H. / Lee, Y.S. / Hyun, J.J. / Jung, Y.K. / Kim, J.H. / Seo, Y.S. / Yeon, J.E. / Byun, K.S. et al. | 2017
- S450
-
Neuroligin4 over expression on natural killer cells cause their impairment in patients with cirrhosis and hepatocellular carcinomaAmer, J. / Salhab, A. / Khalieleh, H. / Safadi, R. et al. | 2017
- S451
-
Comparison of modified (m)RECISTand RECIST 1.1 assessments in the phase 3 RESORCE trial comparing regorafenib and placebo in patients with hepatocellular carcinoma who progressed during sorafenib treatmentBruix, J. / Merle, P. / Granito, A. / Huang, Y.-H. / Bodoky, G. / Pracht, M. / Yokosuka, . / Rosmorduc, O. / Breder, V. / Gerolami, R. et al. | 2017
- S452
-
Improved prediction of survival by a risk factor-integrated inflammatory score in Sorafenib treated hepatocellular carcinomaSprinzl, M.F. / Koch, S. / Seib, M.L. / Weinmann-Menke, J. / Lang, H. / Zöller, D. / Marquardt, J.U. / Wörns, M.-A. / Galle, P.R. / Weinmann, A. et al. | 2017
- S453
-
Validation of the ALBI grade as a substitute for the Child-Pugh class in the BCLC classification of hepatocellular carcinoma and of the additional value provided by the Neutrophil-to-Lymphocyte RatioColombo, M. / Burlone, M.E. / Minh, M.T. / Minisini, R. / Giarda, P. / PInato, D.J. / Pirisi, M. et al. | 2017
- S454
-
External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: a multicenter cohort studyBorzio, M. / Dionigi, E. / Rossini, A. / Marignani, M. / Sacco, R. / De Sio, I. / Bertolini, E. / Francica, G. / Giacomin, A. / Parisi, G. et al. | 2017
- S455
-
Treatment patterns and clinical outcomes for patients with hepatocellular carcinoma from China: a sub-analysis of the Global Hepatocellular Carcinoma BRIDGE StudyChen, M. / Li, L. / Li, H. / Zhang, Y. / Wang, F. / Yan, L. / Bai, Y. / Han, G. / Hu, H. / Qin, S. et al. | 2017
- S456
-
PET/CT findings using 18F-labeled galactose tracer (FDGal) vs. 18F-labeled glucose tracer (FDG) in patients with hepatocellular carcinomaBak-Fredslund, K.P. / Kramer, S. / Villadsen, G.E. / Keiding, S. / Sørensen, M. et al. | 2017
- S457
-
Analysis of the breath metabolome in patients with Hepatocellular carcinomaRifai, G. / Hammad, A. / Elshamy, M. / Mehta, N. / Grove, D. / Lopez, R. / Aucejo, F. / Alkhouri, N. et al. | 2017
- S459
-
Effect of novel AKT inhibitor ARQ 751 as single agent and its combination with sorafenib on hepatocellular carcinoma in a cirrhotic rat modelKeerthi, K. / Jilkova, Z.M. / Roth, G.S. / Abbadessa, G. / Yu, Y. / Marche, P. / Decaens, T. et al. | 2017
- S460
-
PNPLA3 p.I148M risk allele carriers might be at-risk of chemotherapy-associated steatohepatitis (CASH)Casper, M. / Zimmermann, S. / Lammert, F. / Krawczyk, M. et al. | 2017
- S461
-
Hepatocyte nanodelivery using siRNA c-Jun N-terminal Kinase-2 (siJnk2) for the treatment of chronic liver diseaseWoitok, M.M. / Doleschel, D. / Zoubek, M.E. / Kiessling, F. / Lederle, W. / Trautwein, C. / Cubero, F.J. et al. | 2017
- S462
-
Genetic and epigenetic bases of the relationship between reduced OCT1 expression and poor response to sorafenib in hepatocellular carcinoma and cholangiocarcinomaAl-Abdulla, R. / Lozano, E. / Macias, R.I. / O’Rourke, C.J. / Perez, M.J. / Serrano, M.A. / Romero, M.R. / Monte, M.J. / Herraez, E. / Briz, O. et al. | 2017
- S464
-
Extracellular ATP and subsequent purinergic P2Y2 receptor signalling promote liver tumorigenesis in miceSchulien, I. / Hockenjos, B. / Hasselblatt, P. et al. | 2017
- S465
-
Molecular characterization of the immune class of hepatocellular carcinomaMartinez-Quętglas, I. / Sia, D. / Jiao, Y. / Kuchuck, O. / Martin, C.V. / De Moura, M.C. / Putra, J. / Camprecios, G. / Thung, S. / Mazzaferro, V. et al. | 2017
- S466
-
Characterization of cancer associated fibroblasts in primary site and metaststic lymph nodes of intrahepatic cholangiocarcinoma by immunohistochmistryUyama, N. / Kawada, N. / Hirota, S. / Hatano, E. / Fujimoto, J. et al. | 2017
- S467
-
Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenibCho, H.J. / Kim, S.S. / Cho, S.W. / Cheong, J.Y. et al. | 2017
- S468
-
Prevalence and risk factors for hepatitis B infection in the adult population of Georgia: a nationwide surveyKasradze, A. / Kuchukhidze, G. / Baliashvili, D. / Salyer, S. / Gamkrelidze, A. / Tsereteli, M. / Chitadze, N. / Alkhazashvili, M. / Zakhashvili, K. / Drobeniuc, J. et al. | 2017
- S469
-
Prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disordersParfieniuk-Kowerda, A. / Pogorzelska, J. / Lapinski, T.W. / Maciaszek, M. / Swiderska, M. / Grzeszczuk, A. / Naumnik, B. / Rowiński, M. / Jaroszewicz, J. / Flisiak, R. et al. | 2017
- S470
-
Clinical outcomes were comparable between chronic hepatitis B patients with virological response using oral antiviral therapy and inactive carriers when adjusting for fibrotic burdenKim, B.K. / Kim, H.S. / Kim, S.U. / Park, J.Y. / Kim, D.Y. / Ahn, S.H. / Song, K.J. / Han, K.-H. et al. | 2017
- S471
-
2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizing ribavirinQu, C. / Wang, W. / Xu, L. / Yin, Y. / Pan, Q. / Peppelenbosch, M. et al. | 2017
- S473
-
Characterization and evaluation of hepatic fibrosis degree in patients with chronic hepatitis B virus infection with normal transaminasesJuan, C.S. / Casado, M. / Gonzalez, M. / Hallouch, S. / Práxedes, E. / Porcel, A. / Gálvez, A. / Anguita, F. / Vega, J.L. et al. | 2017
- S474
-
The value of subtyping genotype A in chronic hepatitis B: differences in disease course and implications for therapyGonsalkorala, E. / Bruce, M. / Horner, M. / Wang, B. / Carey, I. / Agarwal, K. et al. | 2017
- S475
-
Low viremic HBeAg negative HBsAg carriers: clinical outcome and non invasive diagnostic accuracy for chronic hepatitis B or inactive infection by combinations of HBV markersOliveri, F. / Surace, L. / Cavallone, D. / Colombatto, P. / Ricco, G. / Salvati, N. / Coco, B. / Romagnoli, V. / Gattai, R. / Salvati, A. et al. | 2017
- S477
-
No changes in the coding sequence for HBV core protein after 6 weeks of treatment of HBV infected humanized mice with NVR 3-778Lam, A.M. / Shimada, T. / Dandri, M. / Flores, L. / Klumpp, K. et al. | 2017
- S478
-
Characterization of the intrahepatic immune response of virally-suppressed chronic hepatitis B patients to treatment with the oral TLR7 agonist GS-9620Boeijen, L. / van Oord, G.W. / Hou, J. / van Campenhout, M.J. / van der Heide-Mulder, M. / Gaggar, A. / Li, L. / Fletcher, S.P. / de Knegt, R.J. / Boonstra, A. et al. | 2017
- S479
-
Serum HBV RNA level monitoring for response prediction in HBeAg positive chronic hepatitis B infectionvan Campenhout, M.J. / van Bömmel, F. / Grossmann, M. / Fischer, J.J. / Deichsel, D. / Boonstra, A. / van Vuuren, A.J. / Berg, T. / Hansen, B.E. / Janssen, H.L. et al. | 2017
- S480
-
Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infectionHan, M. / Li, Y. / Wu, W. / Zhang, Y. / Yan, W. / Luo, X. / Ning, Q. et al. | 2017
- S481
-
Quantification of serum hepatitis B core-related antigen to understanding the hepatitis B virus and hepatitis D virus chronic infectionRuiz-Ripa, A. / Riveiro-Barciela, M. / Tabernero, D. / Godoy, C. / Sopena, S. / López-Martínez, R.M. / Buti, M. / Rodríguez-Frías, F. et al. | 2017
- S482
-
Increased hepatitis B virus (HBV) specific IFN-γ and IL17A secretion by T cell subsets in HBV infected non transmitting mothers and their HBV negative new-borns: a Novel mechanism for prevention of HBV vertical transmissionVyas, A.K. / Patra, S. / Islam, M. / Sarin, S.K. / Trehanpati, N. et al. | 2017
- S483
-
Hepatitis B virus quasispecies complexity is lower in hepatitis B virus–hepatitis D virus infection than in hepatitis B virus monoinfectionGodoy, C. / Sopena, S. / Gregori, J. / Tabernero, D. / Homs, M. / Casillas, R. / Ruiz, A. / Riveiro-Barcela, M. / Quer, J. / Esteban, R. et al. | 2017
- S484
-
Proteomic profiling of plasma proteins associated with spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis BLiu, F. / Seto, W.-K. / Wong, D.K.-H. / Sharma, R. / Huang, F.-Y. / Cheung, K.-S. / Fung, J. / Lai, C.-L. / Yuen, M.-F. et al. | 2017
- S485
-
The NLRP3 inflammasome is activated in liver tissue of patients with newly diagnosed chronic hepatitis B virus infectionGermanidis, G. / Molyvdas, A. / Loli, G. / Hytiroglou, P. / Vassiliadis, T. / Lazaridis, N. / Morfesis, P. / Zebekakis, P. / Germenis, A.E. / Speletas, M. et al. | 2017
- S486
-
Prediction for the incidence of hepatocellular carcinoma in patients with chronic hepatitis B after administration of nucleos(t)side analogTakahashi, H. / Okuse, C. / Yamada, N. / Niinuma, T. / Yamamoto, E. / Kai, M. / Wakasugi, H. / Akutsu, N. / Yotsuyanagi, H. / Suzuki, M. et al. | 2017
- S487
-
HBV/HDV co-infection microRNA profile: downregulation of anti-inflammatory and upregulation of pro-apoptotic and viral replication mircoRNAs is associated with HDV RNA replication and HBsAg levelsCarey, I. / Shang, D. / Bruce, M. / Horner, M. / Subramanian, M. / Gaggar, A. / Agarwal, K. et al. | 2017
- S489
-
Integrated healthcare system implementation of one time hepatitis C virus testing for patients born between 1945 and 1965 with linkage to careLevin, J.M. / Huckins, E. et al. | 2017
- S490
-
Linkage to care of HBsAg and anti-HCV positive patients after a systematic screening approach in the German primary care settingLüllau, A. / Petroff, D. / Bätz, O. / Kramer, J. / Jedrysiak, K. / Tenckhoff, H. / Berg, T. / Wolffram, I. / Wiegand, J. et al. | 2017
- S491
-
Sustained viral response following treatment with direct acting antiviral agents for chronic hepatitis C and the risk of hepatocellular carcinomaReddy, K.R. / Bourliere, M. / Agarwal, K. / Lawitz, E. / Osinusi, A. / Kersey, K. / Crans, G. / Moody, S. / Ni, L. / Brainard, D.M. et al. | 2017
- S492
-
Drug-drug interaction profile of sofosbuvir/velpatasvir/ voxilaprevir fixed-dose combinationGarrison, K.L. / Kirby, B. / Stamm, L.M. / Ma, G. / Vu, A. / Ling, J. / Mathias, A. et al. | 2017
- S493
-
Long-term fibrosis improvement after sustained virologic response in patients with chronic hepatitis C and advanced fibrosis or cirrhosis – pre-treatment cirrhosis, older age and high body mass index increases the risk for persisting fibrosisHedenstierna, M. / Nangarhari, A. / Weiland, O. / Aleman, S. et al. | 2017
- S494
-
An approach to hepatitis C Virus epidemiology: analysis in 7602 patients of orthopaedic surgeryPipa-Muniz, M. / Romero, M.I. / Alonso, E.B. / Luengo, M.C. / Trastoy, P.V. / Mata, A.M. / Franco, L. / López, R.G. / Ruiz, E.F. / Muñiz, I.P. et al. | 2017
- S495
-
DAA treatment scale-up in HIV/HCV co-infection: characterisinga population at risk for reinfectionMartinello, M. / Dore, G.J. / Bopage, R.I. / Finlayson, R. / Baker, D. / Bloch, M. / Wilcox, A. / Filep, E. / Hellard, M. / Matthews, G.V. et al. | 2017
- S496
-
Association between improved liver function and selenium depends on C718T polymorphism in 3’- untranslated region of glutathione peroxidase 4 and in humansRohr-Udilova, N. / Theiner, S. / Beinhardt, S. / Stättermayer, A. / Scherzer, T. / Seif, M. / Köllensperger, G. / Keppler, B. / Eder, E. / Willheim, C. et al. | 2017
- S499
-
Epidemiology and treatment of hepatitis C virus infection in China in 2013–2015: a hospital-based population studyChen, Z.-W. / Liu, B. / Li, Z. / Li, H. / Ren, H. / Hu, P. et al. | 2017
- S500
-
A novel single daily fixed dose combination of sofosbuvir 400 mg + ribavirin1000 mg + EGCG 400 mg is superior to the standard of care as an anti-viral and safer causing less hemolysis in patients with chronic hepatitis CShiha, G. / Soliman, R. / Mousa, A. / Mousa, S. et al. | 2017
- S501
-
Rapid liver fibrosis regression after sustained virological response in HCV patients treated with direct acting antiviralsLledó Ibáñez, G.M. / Arias, A. / Benítez-Gutiérrez, L.M. / Cítores, M.J. / Carrasco, I. / Cuervas-Mons, V. / De Mendoza, C. et al. | 2017
- S502
-
An outbreak of acute hepatitis C GT1b in onco-hematological patients. Treatment with Sofosbuvir + Ledipasvir and concomitant chemotherapyBrancaccio, G. / Sorbo, M.C. / Frigeri, F. / Rizzo, V. / Cantone, M. / Genderini, F. / Fabeni, L. / Pinto, A. / Perno, C.F. / Ceccherini-Silberstein, F. et al. | 2017
- S503
-
Elbasvir/grazoprevir plus sofosbuvir in treatment-naive and treatment-experienced cirrhotic patients with hepatitis C virus genotype 3 infection treated for 8, 12, or 16 weeks: final results of the C-ISLE studyFoster, G.R. / Agarwal, K. / Cramp, M.E. / Moreea, S. / Barclay, S. / Collier, J. / Brown, A.S. / Ryder, S.D. / Ustianowski, A. / Forton, D.M. et al. | 2017
- S504
-
Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treatmentFoster, G. / Agarwal, K. / Cramp, M.E. / Moreea, S. / Barclay, S. / Collier, J. / Brown, A.S. / Ryder, S.D. / Ustianowski, A. / Forton, D.M. et al. | 2017
- S505
-
Modeling vaccine and DAA treatment scale up effect on hepatitis C prevalence among persons who inject drugs in metropolitan ChicagoEchevarria, D. / Gutfraind, A. / Boodram, B. / Cotler, S.J. / Major, M. / Dahari, H. et al. | 2017
- S506
-
Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drugNazario, H.E. / Modi, A.A. / Ndungu, M. / Ramirez, R. / Tujague, L. / Weinstein, J.S. et al. | 2017
- S507
-
Impact of directly acting antiviral drugs during treatment of decompensated cirrhosis with chronic hepatitis CNayak, H.K. / Kumar, K. / Pande, G. / Mohindra, S. / Saraswat, V.A. et al. | 2017
- S508
-
Ribavirin free versus Ribavirin containing therapy with all second generation direct acting antivirals for the treatment of hepatitis C virus genotype 1 infection; a pooled analysis of 4501 patientsAhmed, H. / Abushouk, A.I. / Menshawy, A. / Attia, A. / Negida, A. / Loutfy, S.A. et al. | 2017
- S509
-
Response guided addition of Sofosbuvir to pegylated interferon and ribavirin cures greater than 90% of patients with Genotype 3 infection and F0–2 diseaseHay, I. / Cairns, H. / Fox, R. / Datta, S. / Barclay, S.T. et al. | 2017
- S510
-
Efficacy of oral Direct Acting Antivirals for the treatment of chronic hepatitis/cirhhosis due to hepatitis C virus infection: the real-life experience of the Sicily RegistryCacciola, I. / Petta, S. / Di Stefano, M. / Cannavò, M.R. / Davì, A. / Madonia, S. / Calvaruso, V. / Rocca, L.L. / Di Lorenzo, F. / Digiacomo, A. et al. | 2017
- S511
-
Relapse post DAA therapy: are we too focussed on RAV and neglecting ribavirin?Carey, I. / Cannon, M. / Verma, S. / Bruce, M. / Childs, K. / Considine, A. / Agarwal, K. et al. | 2017
- S512
-
Projection of patients who fail treatment in the era of direct-acting antiviralsChhatwal, J. / Chen, Q. / Ayer, T. / Kanwal, F. / Wang, X. / Roberts, M.S. / Fagiuoli, S. / Petersen, J. et al. | 2017
- S513
-
SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapyGrebely, J. / Jacobson, I.M. / Kayali, Z. / Verna, E.C. / Shiffman, M.L. / Hyland, R.H. / Stamm, L.M. / Huang, K.C. / Brainard, D.M. / McHutchison, J.G. et al. | 2017
- S514
-
HepCom: impact of co-morbidities on the final success of direct antiviral agents therapy in hepatitis CAmpuero, J. / Maté, C.J. / Quiles, R. / Palomo, N. / Rosales, J.M. / Llerena, S. / Cordero, P. / Serrano, F.J. / Urquijo, J.J. / Maraver, M. et al. | 2017
- S515
-
Analysis of the real-world treatment effectiveness of elbasvir/grazoprevirMc Combs, J.S. / McGinnis, J. / Fox, S. / Tonnu-Mihara, I. et al. | 2017
- S517
-
Changes in markers of liver function in hepatitis C virus genotype 1b Asian patients with compensated cirrhosis treated with ombitasvir/paritaprevir/ritonavir plus dasabuvir with ribavirin in the ONYX-II studyHeo, J. / Luo, Y. / Chuang, W.-L. / Jia, J. / Han, K.-H. / Yu, M.-L. / Tang, H. / Lim, Y.-S. / Peng, C.-Y. / Xu, M. et al. | 2017
- S518
-
Total cholesterol and low-density lipoprotein increases after treatment with direct-acting antiviral agents – Implications in the future?Carvalho, J.R.O.A.S. / Serejo, F. / Velosa, J. et al. | 2017
- S519
-
Use of the 6 million viral load cut-off to guide treatment duration with ledipasvir/sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection: results from the German Hepatitis C-Registry (DHC-R)Vermehren, J. / Athmann, C. / Günther, R. / Schott, E. / Pathil, A. / Boeker, K.H. / Cornberg, M. / Niederau, C. / Simon, K.-G. / Maasoumy, B. et al. | 2017
- S520
-
Efficacy and safety of Simeprevir-containing hepatitis C therapy in patients on opiate substitution therapyDillon, J. / Mauss, S. / Nalpas, C. / Bicer, C. / Schlag, M. / Lonjon-Domanec, I. / Jessner, W. / Beumont-Mauviel, M. / Kalmeijer, R. et al. | 2017
- S521
-
Impact of elbasvir/grazoprevir (EBR/GZR) on health-related quality of life (HRQOL) and fatigue in patients with chronic hepatitis C virus (HCV) infection and inherited blood disorders (IBLD): data from the C-EDGE IBLD studyVierling, J.M. / Sobhonslidsuk, A. / Papatheodoridis, G. / Assy, N. / Rosenberg, W. / Guyader, D. / Dev, A. / Gordon, S.C. / Pol, S. / Luketic, V.A. et al. | 2017
- S522
-
Adherence to SmPC recommendations in real-world practice in the treatment of monoinfected patients with chronic genotype 1 or 4 HCV infection with direct-acting antiviralsRuiz-Antorán, B. / Rincón, D. / Perelló, C. / Fernandez, I. / Gea, F. / Mariño, Z. / García-Samaniego, J. / Hontangas, V. / Cabezas, J. / Sacristan, B. et al. | 2017
- S523
-
Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practiceRuiz-Antorán, B. / Rincón, D. / Conde, M.H. / Fernández, I. / García-Samaniego, J. / Gea, F. / Cabezas, J. / Sacristán, B. / Jorquera, F. / Turnes, J. et al. | 2017
- S524
-
Suitability of HCV treatment in primary care settings for individuals with HIV/hepatitis C coinfectionDoyle, J.S. / Bowring, A.L. / Iser, D.M. / Sasadeusz, J. / Roney, J. / O’Reilly, M. / Fairley, C. / Gane, E. / Hoy, J. / Matthews, G.V. et al. | 2017
- S526
-
Efficacy of therapy against chronic hepatitis C virus genotype 1 infection in HIV-coinfected patients with several interferon-free DAA combinations: real life data from the HEPAVIR-DAA CohortNeukam, K. / Téllez, F. / Morano-Amado, L.E. / Rivero-Juárez, A. / Nuño-Álvarez, E. / Ríos, M.J. / Macías, J. / Merino, D. / Pérez-Pérez, M. / Pineda, J.A. et al. | 2017
- S528
-
Benefit of direct-acting antiviral therapy in hepatitis C virus (HCV) monoinfected and HIV-HCV coinfected patients with mixed cryoglobulinemiaDiakite, M. / Hartig-Lavie, K. / Miailhes, P. / Pradat, P. / Uhrés, A.-C. / Zoulim, F. / Sarda, M.-N. et al. | 2017
- S529
-
Safety and efficacy of ombitasvir/paritaprevir/ritonavir ± dasabuvir and ± ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3–6)Agarwal, K. / Brown, R.S. / Dumas, E.O. / McCaughan, G.W. / Samuel, D. / Terrault, N. / Brown, K.A. / Mantry, P.S. / Berenguer, M. / Kwo, P.Y. et al. | 2017
- S531
-
Comparison of efficacy and safety of ombitasvir/paritaprevir/ ritonavir and dasabuvir ± ribavirin between Asian and western HCV GT1b-infected patientsWei, L. / Luo, Y. / Chuang, W.-L. / Paik, S.W. / Yu, M.-L. / Fredrick, L.M. / Campbell, A. / Trinh, R. / Enejosa, J. / Shulman, N.S. et al. | 2017
- S533
-
In vitro virology profile of the 3 direct-acting antiviral combination of AL-335, odalasvir and simeprevirVijgen, L. / Fevery, B. / Jekle, A. / Shaw, K. / Tan, H. / Lenz, O. / Symons, J. / De Meyer, S. et al. | 2017
- S534
-
Decrease of Interleukin-6 and Interleukin-8 blood levels after successful interferon-free anti-HCV treatmentBadia, L. / Rinaldi, M. / Assirelli, C. / Rossi, N. / Guardigni, V. / Viale, P. / Verucchi, G. et al. | 2017
- S535
-
Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)Kondili, L.A. / Di Leo, A. / Iannone, A. / Santantonio, T. / Giammario, A. / Raimondo, G. / Filomia, R. / Coppola, C. / Amoruso, D. / Blanc, P. et al. | 2017
- S536
-
The old patient in DAA era: real life reports on 5925 patients from the Lombardy HCV NetworkPasulo, L. / Aghemo, A. / Fargion, S. / Spinetti, A. / Cologni, G. / Maggiolo, F. / Rizzardini, G. / Puoti, M. / Bruno, R. / Minoli, L. et al. | 2017
- S537
-
Hepatitis E virus-specific T cell responses against non-structural viral proteins in patients with ongoing and resolved hepatitis EAl-Ayoubi, J. / Behrendt, P. / Bremer, B. / Gisa, A. / Rinker, F. / Manns, M.P. / Cornberg, M. / Wedemeyer, H. / Kraft, A.R.M. et al. | 2017
- S538
-
Comprehensive immune changes associated with HCV direct-acting antiviral curesSlauenwhite, D. / Arseneault, K. / Brisseau, C. / Oldford, S. / Barrett, L. et al. | 2017
- S539
-
KLRG1 impairs antiviral immunity of NK-cell in Individuals with Chronic Hepatitis B Virus Infection via the Akt pathwayLi, M.-H. / Yin, W.-W. / Zhang, Q.-F. / Liu, Q. / Li, Y.-L. / Shao, J.-Y. / Hu, H.-D. / Ren, H. / Hu, P. / Zhang, D.-Z. et al. | 2017
- S541
-
Myeloid-Derived Suppressor Cells: key players mediating immunosuppression via induction of Regulatory T-cell by TGFβ and IL-10 driven pathways in chronic HBV infectionPal, S. / Nandi, M. / Dey, D. / Ahammed, S.M. / Banerjee, S. / Santra, A. / Chowdhury, A. / Datta, S. et al. | 2017
- S543
-
The GLOBE score identifies PBC patients at increased risk of liver transplantation or death in different age-categories over timeGoet, J.C. / Lammers, W.J. / Floreani, A. / Pares, A. / Janssen, H.L.A. / Hirschfield, G.M. / Van Buuren, H.R. / Corpechot, C. / Invernizzi, P. / Lindor, K.D. et al. | 2017
- S544
-
Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumabWilliamson, K.D. / Slevin, S. / Willberg, C. / Chapman, R. / Klenerman, P. / Keshav, S. et al. | 2017
- S545
-
The interpretation of follow-up 3D-magnetic resonance cholangiopancreatography/magnetic resonance imaging in patients with primary sclerosing cholangitis is difficult and highly variable even between experienced specialistsZenouzi, R. / Yamamura, J. / Keller, S. / Weiler-Normann, C. / Sebode, M. / Lohse, A.W. / Schramm, C. et al. | 2017
- S546
-
Health related quality of life (HRQoL) in patients with AIH: a prospective, single centre studyKruk, B. / Janik, M.K. / Raszeja-Wyszomirska, J. / Krawczyk, M. / Milkiewicz, P. et al. | 2017
- S547
-
Dynamic risk prediction in Primary Biliary Cholangitis using the UK-PBC cohortCarbone, M. / Nardi, A. / Ainsworth, H. / Heneghan, M.A. / Hirschfield, G.M. / Thorburn, D. / Bathgate, A. / Aldersley, M. / Neuberger, J.M. / Stocken, D. et al. | 2017
- S548
-
Non-invasiveevaluationofliverfibrosisinautoimmunehepatitis: still a challengeFerraz, M.L.C.G. / Oliveira, E. / Perez, R.M. / Dellavance, A.L.C.G. / Andrade, L.E. / Lanzoni, V.P. et al. | 2017
- S549
-
Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody positive subjectsZandanell, S. / Feldman, A. / Denkmayr, L. / Strasser, M. / Ruhaltinger, S. / Strebinger, G. / Huber-Schönauer, U. / Niederseer, D. / Stechemesser, L. / Paulweber, B. et al. | 2017
- S550
-
Tolerability and efficacy of 6-mercaptopurin in patients with autoimmune liver disease and azathioprine intoleranceElnegouly, M. / Kraus, M.R. / Zoller, H. / Umgelter, A. / Geisler, F. et al. | 2017
- S551
-
Geoepidemiology, clinical manifestations and outcome of a large cohort of primary biliary cholangitis patients in GreeceGatselis, N.K. / Zachou, K. / Lygoura, V. / Azariadis, K. / Arvaniti, P. / Spyrou, E. / Papadamou, G. / Koukoulis, G.K. / Dalekos, G.N. / Rigopoulou, E.I. et al. | 2017
- S553
-
T cell interactions with the biliary epithelium in primary biliary cholangitisEtherington, R.E. / Millar, B. / Innes, B. / Brain, J. / Kirby, J. / Jones, D. et al. | 2017
- S554
-
The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosisKummen, M. / Holm, K. / Vesterhus, M. / Trøseid, M. / Melum, E. / Aukrust, P. / Karlsen, T.H. / Hov, J.R. et al. | 2017
- S555
-
Expression of the bile acid receptor TGR5 in livers of PSC patients and Mdr2-/- (Abcb4-/-) miceReich, M. / Spomer, L. / Hoehne, J. / Hov, J.E. / Karlsen, T.H. / Nierhoff, D. / Häussinger, D. / Keitel, V. et al. | 2017
- S556
-
Melatonin levels are significantly decreased in liver tissues of patients with Primary Biliary CholangitisWasik, U. / Milkiewicz, P. / Milkiewicz, M. et al. | 2017